Preview
Sign-in for full Details 
Sign-in free and Explore the Exciting World of BiomedExperts:
- Over 1.500.000 Profiles
- More than 1.800 Organizations worldwide
- State of the Art Network Visualizations
- Manage your own Profile
- Locate Experts in your Country/Region
- Locate Experts in your 1. and 2. Level Network
- Connect to Experts Worldwide
NetworkView
Peter Scardino
This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers
together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles
free of charge to researchers worldwide.
Research Profile (preview)
Disorders
Procedures
Chemicals & Drugs
Concepts & Ideas
Anatomy
Physiology
Sign-in to see full Profile
Network (preview)
120
Kattan, Michael
90
Eastham, James
79
Wheeler, Thomas
48
Ohori, Makoto
34
Hricak, Hedvig
31
Vickers, Andrew
30
Bianco, Fernando
28
Slawin, Kevin
27
Thompson, Timothy
27
Reuter, Victor
17
Lilja, Hans
16
Kuroiwa, Kentaro
16
Huland, Hartwig
15
Fearn, Paul
14
Cagiannos, Ilias
Sign-in to see all Coauthors
Publications
Sign-in to see all Publications
Sign in free and see...
Visualized networks:
See your personal network in
sophisticated graphical views
GeoTargeted Searches:
Locate experts around the world
and connect with global collaborators
Research Profiles:
See the visualized research activity
of experts around the globe
Sign-in to see more
Geonetwork of Peter Scardino (preview)
Cities where this author has publications
Cities where co-authors of this author have publications
Sign-in to see more
All Publications
-
2009: Rabbani Farhang; Patel Manish; Cozzi Paul; Mulhall John P; Scardino Peter T
Recovery of erectile function after radical prostatectomy is quantitatively related to the response to intraoperative cavernous nerve stimulation.
BJU international 2009;104(9):1252-7.
-
2009: Stephenson Andrew J; Wood David P; Kattan Michael W; Klein Eric A; Scardino Peter T; Eastham James A; Carver Brett S
Location, extent and number of positive surgical margins do not improve accuracy of predicting prostate cancer recurrence after radical prostatectomy.
The Journal of urology 2009;182(4):1357-63.
-
2009: Haarer Chadwick F; Gopalan Anuradha; Tickoo Satish K; Scardino Peter T; Eastham James A; Reuter Victor E; Fine Samson W
Prostatic transition zone directed needle biopsies uncommonly sample clinically relevant transition zone tumors.
The Journal of urology 2009;182(4):1337-41.
-
2009: Rabbani Farhang; Vora Kinjal C; Yunis Luis Herran; Eastham James A; Guillonneau Bertrand; Scardino Peter T; Touijer Karim
Biochemical recurrence rate in patients with positive surgical margins at radical prostatectomy with further negative resected tissue.
BJU international 2009;104(5):605-10.
-
2009: Stephenson Andrew J; Kattan Michael W; Eastham James A; Bianco Fernando J; Yossepowitch Ofer; Vickers Andrew J; Klein Eric A; Wood David P; Scardino Peter T
Prostate cancer-specific mortality after radical prostatectomy for patients treated in the prostate-specific antigen era.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009;27(26):4300-5.
-
2009: Pettus Joseph A; Masterson Timothy; Sokol Alexander; Cronin Angel M; Savage Caroline; Sandhu Jaspreet S; Mulhall John P; Scardino Peter T; Rabbani Farhang
Prostate size is associated with surgical difficulty but not functional outcome at 1 year after radical prostatectomy.
The Journal of urology 2009;182(3):949-55.
-
2009: O'Brien Matthew Frank; Cronin Angel M; Fearn Paul A; Smith Brandon; Stasi Jason; Guillonneau Bertrand; Scardino Peter T; Eastham James A; Vickers Andrew J; Lilja Hans
Pretreatment prostate-specific antigen (PSA) velocity and doubling time are associated with outcome but neither improves prediction of outcome beyond pretreatment PSA alone in patients treated with radical prostatectomy.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009;27(22):3591-7.
-
2009: Valdagni Riccardo; Scardino Peter T; Denis Louis
The 2008 European School of Oncology inside track conference, "predictive modeling in prostate cancer".
Cancer 2009;115(13 Suppl):3035-8.
-
2009: Touijer Karim; Scardino Peter T
Nomograms for staging, prognosis, and predicting treatment outcomes.
Cancer 2009;115(13 Suppl):3107-11.
-
2009: Shukla-Dave Amita; Hricak Hedvig; Ishill Nicole; Moskowitz Chaya S; Drobnjak Marija; Reuter Victor E; Zakian Kristen L; Scardino Peter T; Cordon-Cardo Carlos
Prediction of prostate cancer recurrence using magnetic resonance imaging and molecular profiles.
Clinical cancer research : an official journal of the American Association for Cancer Research 2009;15(11):3842-9.
-
2009: Scardino Peter T
Safety in surgery: the checklist.
Nature reviews. Urology 2009;6(5):235.
-
2009: Li Rile; Dai Hong; Wheeler Thomas M; Sayeeduddin Mohammad; Scardino Peter T; Frolov Anna; Ayala Gustavo E
Prognostic value of Akt-1 in human prostate cancer: a computerized quantitative assessment with quantum dot technology.
Clinical cancer research : an official journal of the American Association for Cancer Research 2009;15(10):3568-73.
-
2009: Carver Brett S; Tran Jennifer; Gopalan Anuradha; Chen Zhenbang; Shaikh Safa; Carracedo Arkaitz; Alimonti Andrea; Nardella Caterina; Varmeh Shohreh; Scardino Peter T; Cordon-Cardo Carlos; Gerald William; Pandolfi Pier Paolo
Aberrant ERG expression cooperates with loss of PTEN to promote cancer progression in the prostate.
Nature genetics 2009;41(5):619-24.
-
2009: Bloom David A; Scardino Peter T
Peter Lester Scardino--a genitourinary surgeon in third generation of the specialty: part 2.
Urology 2009;73(5):944-6.
-
2009: Bloom David A; Scardino Peter T
Peter Lester Scardino--a genitourinary surgeon in third generation of the specialty: part 1.
Urology 2009;73(5):940-3.
-
2009: Brame Ryan S; Zaider Marco; Zakian Kristen L; Koutcher Jason A; Shukla-Dave Amita; Reuter Victor E; Zelefsky Michael J; Scardino Peter T; Hricak Hedvig
Regarding the focal treatment of prostate cancer: inference of the Gleason grade from magnetic resonance spectroscopic imaging.
International journal of radiation oncology, biology, physics 2009;74(1):110-4.
-
2009: Scardino Peter T
Focal therapy for prostate cancer.
Nature reviews. Urology 2009;6(4):175.
-
2009: Helo Pauliina; Cronin Angel M; Danila Daniel C; Wenske Sven; Gonzalez-Espinoza Rita; Anand Aseem; Koscuiszka Michael; Väänänen Riina-Minna; Pettersson Kim; Chun Felix K-H; Steuber Thomas; Huland Hartwig; Guillonneau Bertrand D; Eastham James A; Scardino Peter T; Fleisher Martin; Scher Howard I; Lilja Hans
Circulating prostate tumor cells detected by reverse transcription-PCR in men with localized or castration-refractory prostate cancer: concordance with CellSearch assay and association with bone metastases and with survival.
Clinical chemistry 2009;55(4):765-73.
-
2009: Eggener Scott E; Mueller Alex; Berglund Ryan K; Ayyathurai Raj; Soloway Cindy; Soloway Mark S; Abouassaly Robert; Klein Eric A; Jones Steven J; Zappavigna Chris; Goldenberg Larry; Scardino Peter T; Eastham James A; Guillonneau Bertrand
A multi-institutional evaluation of active surveillance for low risk prostate cancer.
The Journal of urology 2009;181(4):1635-41; discussion 1641.
-
2009: Berney D M; Gopalan A; Kudahetti S; Fisher G; Ambroisine L; Foster C S; Reuter V; Eastham J; Moller H; Kattan M W; Gerald W; Cooper C; Scardino P; Cuzick J
Ki-67 and outcome in clinically localised prostate cancer: analysis of conservatively treated prostate cancer patients from the Trans-Atlantic Prostate Group study.
British journal of cancer 2009;100(6):888-93.
-
2009: Thompson R Houston; Eastham James A; Scardino Peter T; Sheinfeld Joel
Critical elements in fellowship training.
Urologic oncology 2009;27(2):199-204.
-
2009: Scardino Peter T
Training of a surgeon-scientist.
Urologic oncology 2009;27(2):129.
-
2009: Shukla-Dave Amita; Hricak Hedvig; Ishill Nicole M; Moskowitz Chaya S; Drobnjak Marija; Reuter Victor E; Zakian Kristen L; Scardino Peter T; Cordon-Cardo Carlos
Correlation of MR imaging and MR spectroscopic imaging findings with Ki-67, phospho-Akt, and androgen receptor expression in prostate cancer.
Radiology 2009;250(3):803-12.
-
2009: Kattan Michael W; Vickers Andrew J; Yu Changhong; Bianco Fernando J; Cronin Angel M; Eastham James A; Klein Eric A; Reuther Alwyn M; Edson Pontes Jose; Scardino Peter T
Preoperative and postoperative nomograms incorporating surgeon experience for clinically localized prostate cancer.
Cancer 2009;115(5):1005-10.
-
2009: Paparel Philippe; Akin Oguz; Sandhu Jaspreet S; Otero Javier Romero; Serio Angel M; Scardino Peter T; Hricak Hedvig; Guillonneau Bertrand
Recovery of urinary continence after radical prostatectomy: association with urethral length and urethral fibrosis measured by preoperative and postoperative endorectal magnetic resonance imaging.
European urology 2009;55(3):629-37.
-
2009: Carver Brett S; Tran Jennifer; Chen Zhenbang; Carracedo-Perez Arkaitz; Alimonti Andrea; Nardella Caterina; Gopalan Anuradha; Scardino Peter T; Cordon-Cardo Carlos; Gerald William; Pandolfi Pier Paolo
ETS rearrangements and prostate cancer initiation.
Nature 2009;457(7231):E1; discussion E2-3.
-
2009: Gopalan Anuradha; Leversha Margaret A; Satagopan Jaya M; Zhou Qin; Al-Ahmadie Hikmat A; Fine Samson W; Eastham James A; Scardino Peter T; Scher Howard I; Tickoo Satish K; Reuter Victor E; Gerald William L
TMPRSS2-ERG gene fusion is not associated with outcome in patients treated by prostatectomy.
Cancer research 2009;69(4):1400-6.
-
2009: Eastham James; Tokuda Yuji; Scardino Peter
Trends in radical prostatectomy.
International journal of urology : official journal of the Japanese Urological Association 2009;16(2):151-60.
-
2009: Secin Fernando P; Bianco Fernando J; Cronin Angel; Eastham James A; Scardino Peter T; Guillonneau Bertrand; Vickers Andrew J;
Is it necessary to remove the seminal vesicles completely at radical prostatectomy? decision curve analysis of European Society of Urologic Oncology criteria.
The Journal of urology 2009;181(2):609-13; discussion 614.
-
2009: Wenske Sven; Korets Ruslan; Cronin Angel M; Vickers Andrew J; Fleisher Martin; Scher Howard I; Pettersson Kim; Guillonneau Bertrand; Scardino Peter T; Eastham James A; Lilja Hans
Evaluation of molecular forms of prostate-specific antigen and human kallikrein 2 in predicting biochemical failure after radical prostatectomy.
International journal of cancer. Journal international du cancer 2009;124(3):659-63.
-
2009: Valdagni Riccardo; Scardino Peter T; Denis Louis; Kattan Michael W
Predictive modeling in prostate cancer: a conference summary.
European urology 2009;55(2):300-2.
-
2009: Paparel Philippe; Cronin Angel M; Savage Caroline; Scardino Peter T; Eastham James A
Oncologic outcome and patterns of recurrence after salvage radical prostatectomy.
European urology 2009;55(2):404-10.
-
2009: Eggener Scott E; Vickers Andrew J; Serio Angel M; Donovan Michael J; Khan Faisal M; Bayer-Zubek Valentina; Verbel David; Cordon-Cardo Carlos; Reuter Victor E; Bianco Fernando J; Scardino Peter T
Comparison of models to predict clinical failure after radical prostatectomy.
Cancer 2009;115(2):303-10.
-
2009: Lowrance William T; Scardino Peter T
Predictive models for newly diagnosed prostate cancer patients.
Reviews in urology 2009;11(3):117-26.
-
2009: Vickers Andrew J; Scardino Peter T
The clinically-integrated randomized trial: proposed novel method for conducting large trials at low cost.
Trials 2009;10():14.
-
2008: Marberger Michael; Carroll Peter R; Zelefsky Michael J; Coleman Jonathan A; Hricak Hedvig; Scardino Peter T; Abenhaim Lucien L
New treatments for localized prostate cancer.
Urology 2008;72(6 Suppl):S36-43.
-
2008: Penson David F; Rossignol Michel; Sartor A Oliver; Scardino Peter T; Abenhaim Lucien L
Prostate cancer: epidemiology and health-related quality of life.
Urology 2008;72(6 Suppl):S3-11.
-
2008: Sartor A Oliver; Hricak Hedvig; Wheeler Thomas M; Coleman Jonathan; Penson David F; Carroll Peter R; Rubin Mark A; Scardino Peter T
Evaluating localized prostate cancer and identifying candidates for focal therapy.
Urology 2008;72(6 Suppl):S12-24.
-
2008: Scardino Peter T; Abenhaim Lucien L
Focal therapy for prostate cancer: analysis by an international panel.
Urology 2008;72(6 Suppl):S1-2.
-
2008: Schröder Fritz H; Roach Mack; Scardino Peter
Clinical decisions. Management of prostate cancer.
The New England journal of medicine 2008;359(24):2605-9.
-
2008: Shariat Shahrokh F; Scardino Peter T; Lilja Hans
Screening for prostate cancer: an update.
The Canadian journal of urology 2008;15(6):4363-74.
-
2008: Trabulsi Edouard J; Valicenti Richard K; Hanlon Alexandra L; Pisansky Thomas M; Sandler Howard M; Kuban Deborah A; Catton Charles N; Michalski Jeff M; Zelefsky Michael J; Kupelian Patrick A; Lin Daniel W; Anscher Mitchell S; Slawin Kevin M; Roehrborn Claus G; Forman Jeffrey D; Liauw Stanley L; Kestin Larry L; DeWeese Theodore L; Scardino Peter T; Stephenson Andrew J; Pollack Alan
A multi-institutional matched-control analysis of adjuvant and salvage postoperative radiation therapy for pT3-4N0 prostate cancer.
Urology 2008;72(6):1298-302; discussion 1302-4.
-
2008: Garcia Joaquin J; Al-Ahmadie Hikmat A; Gopalan Anuradha; Tickoo Satish K; Scardino Peter T; Reuter Victor E; Fine Samson W
Do prostatic transition zone tumors have a distinct morphology?
The American journal of surgical pathology 2008;32(11):1709-14.
-
2008: Donovan Michael J; Hamann Stefan; Clayton Mark; Khan Faisal M; Sapir Marina; Bayer-Zubek Valentina; Fernandez Gerardo; Mesa-Tejada Ricardo; Teverovskiy Mikhail; Reuter Victor E; Scardino Peter T; Cordon-Cardo Carlos
Systems pathology approach for the prediction of prostate cancer progression after radical prostatectomy.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(24):3923-9.
-
2008: Attard G; Clark J; Ambroisine L; Mills I G; Fisher G; Flohr P; Reid A; Edwards S; Kovacs G; Berney D; Foster C; Massie C E; Fletcher A; De Bono J S; Scardino P; Cuzick J; Cooper C S;
Heterogeneity and clinical significance of ETV1 translocations in human prostate cancer.
British journal of cancer 2008;99(2):314-20.
-
2008: Vickers Andrew; Lilja Hans; Scardino Peter
Five genetic variants associated with prostate cancer.
The New England journal of medicine 2008;358(25):2740; author reply 2741.
-
2008: Tomlins Scott A; Rhodes Daniel R; Yu Jianjun; Varambally Sooryanarayana; Mehra Rohit; Perner Sven; Demichelis Francesca; Helgeson Beth E; Laxman Bharathi; Morris David S; Cao Qi; Cao Xuhong; Andrén Ove; Fall Katja; Johnson Laura; Wei John T; Shah Rajal B; Al-Ahmadie Hikmat; Eastham James A; Eggener Scott E; Fine Samson W; Hotakainen Kristina; Stenman Ulf-Håkan; Tsodikov Alex; Gerald William L; Lilja Hans; Reuter Victor E; Kantoff Phillip W; Scardino Peter T; Rubin Mark A; Bjartell Anders S; Chinnaiyan Arul M
The role of SPINK1 in ETS rearrangement-negative prostate cancers.
Cancer cell 2008;13(6):519-28.
-
2008: Klein Eric A; Bianco Fernando J; Serio Angel M; Eastham James A; Kattan Michael W; Pontes J Edson; Vickers Andrew J; Scardino Peter T
Surgeon experience is strongly associated with biochemical recurrence after radical prostatectomy for all preoperative risk categories.
The Journal of urology 2008;179(6):2212-6; discussion 2216-7.
-
2008: Eastham James A; Scardino Peter T; Kattan Michael W
Predicting an optimal outcome after radical prostatectomy: the trifecta nomogram.
The Journal of urology 2008;179(6):2207-10; discussion 2210-1.
-
2008: Mulhall John P; Müller Alexander; Donohue John F; Golijanin Dragan; Tal Raanan; Akin-Olugbade Yemi; Kobylarz Keith; Cohen-Gould Leona; Bennett Nelson E; Scardino Peter
FK506 and erectile function preservation in the cavernous nerve injury model: optimal dosing and timing.
The journal of sexual medicine 2008;5(6):1334-44.
-
2008: Swindle Peter; Eastham James A; Ohori Makoto; Kattan Michael W; Wheeler Thomas; Maru Norio; Slawin Kevin; Scardino Peter T
Do margins matter? The prognostic significance of positive surgical margins in radical prostatectomy specimens.
The Journal of urology 2008;179(5 Suppl):S47-51.
-
2008: Touijer Karim; Eastham James A; Secin Fernando P; Romero Otero Javier; Serio Angel; Stasi Jason; Sanchez-Salas Rafael; Vickers Andrew; Reuter Victor E; Scardino Peter T; Guillonneau Bertrand
Comprehensive prospective comparative analysis of outcomes between open and laparoscopic radical prostatectomy conducted in 2003 to 2005.
The Journal of urology 2008;179(5):1811-7; discussion 1817.
-
2008: Mulhall John P; Müller Alexander; Donohue John F; Mullerad Michael; Kobylarz Keith; Paduch Darius A; Tal Raanan; Li Philip S; Cohen-Gould Leona; Scardino Peter T
The functional and structural consequences of cavernous nerve injury are ameliorated by sildenafil citrate.
The journal of sexual medicine 2008;5(5):1126-36.
-
2008: Vickers Andrew J; Bianco Fernando J; Gonen Mithat; Cronin Angel M; Eastham James A; Schrag Deborah; Klein Eric A; Reuther Alwyn M; Kattan Michael W; Pontes J Edson; Scardino Peter T
Effects of pathologic stage on the learning curve for radical prostatectomy: evidence that recurrence in organ-confined cancer is largely related to inadequate surgical technique.
European urology 2008;53(5):960-6.
-
2008: Yossepowitch Ofer; Eggener Scott E; Serio Angel M; Carver Brett S; Bianco Fernando J; Scardino Peter T; Eastham James A
Secondary therapy, metastatic progression, and cancer-specific mortality in men with clinically high-risk prostate cancer treated with radical prostatectomy.
European urology 2008;53(5):950-9.
-
2008: Ouyang Xuesong; Jessen Walter J; Al-Ahmadie Hikmat; Serio Angel M; Lin Yong; Shih Weichung-Joseph; Reuter Victor E; Scardino Peter T; Shen Michael M; Aronow Bruce J; Vickers Andrew J; Gerald William L; Abate-Shen Cory
Activator protein-1 transcription factors are associated with progression and recurrence of prostate cancer.
Cancer research 2008;68(7):2132-44.
-
2008: Zelefsky Michael J; Reuter Victor E; Fuks Zvi; Scardino Peter; Shippy Alison
Influence of local tumor control on distant metastases and cancer related mortality after external beam radiotherapy for prostate cancer.
The Journal of urology 2008;179(4):1368-73; discussion 1373.
-
2008: Richstone Lee; Bianco Fernando J; Shah Hiral H; Kattan Michael W; Eastham James A; Scardino Peter T; Scherr Douglas S
Radical prostatectomy in men aged >or=70 years: effect of age on upgrading, upstaging, and the accuracy of a preoperative nomogram.
BJU international 2008;101(5):541-6.
-
2008: Müller Alexander; Tal Raanan; Donohue John F; Akin-Olugbade Yemi; Kobylarz Keith; Paduch Darius; Cutter Suzanne C; Mehrara Babak J; Scardino Peter T; Mulhall John P
The effect of hyperbaric oxygen therapy on erectile function recovery in a rat cavernous nerve injury model.
The journal of sexual medicine 2008;5(3):562-70.
-
2008: Clark J; Attard G; Jhavar S; Flohr P; Reid A; De-Bono J; Eeles R; Scardino P; Cuzick J; Fisher G; Parker M D; Foster C S; Berney D; Kovacs G; Cooper C S
Complex patterns of ETS gene alteration arise during cancer development in the human prostate.
Oncogene 2008;27(14):1993-2003.
-
2008: Ulmert David; Serio Angel M; O'Brien Matthew F; Becker Charlotte; Eastham James A; Scardino Peter T; Björk Thomas; Berglund Göran; Vickers Andrew J; Lilja Hans
Long-term prediction of prostate cancer: prostate-specific antigen (PSA) velocity is predictive but does not improve the predictive accuracy of a single PSA measurement 15 years or more before cancer diagnosis in a large, representative, unscreened population.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(6):835-41.
-
2008: Scardino Peter T
Urology: a long history of innovation.
Nature clinical practice. Urology 2008;5(2):59.
-
2008: Al-Ahmadie Hikmat A; Tickoo Satish K; Olgac Semra; Gopalan Anuradha; Scardino Peter T; Reuter Victor E; Fine Samson W
Anterior-predominant prostatic tumors: zone of origin and pathologic outcomes at radical prostatectomy.
The American journal of surgical pathology 2008;32(2):229-35.
-
2008: Eastham James A; Kattan Michael W; Fearn Paul; Fisher Gabrielle; Berney Daniel M; Oliver Tim; Foster Christopher S; Møller Henrik; Reuter Victor; Cuzick Jack; Scardino Peter;
Local progression among men with conservatively treated localized prostate cancer: results from the Transatlantic Prostate Group.
European urology 2008;53(2):347-54.
-
2008: Scardino Peter T
Localized prostate cancer is rarely a fatal disease.
Nature clinical practice. Urology 2008;5(1):1.
-
2008: Shukla-Dave Amita; Hricak Hedvig; Scardino Peter T
Imaging low-risk prostate cancer.
Current opinion in urology 2008;18(1):78-86.
-
2008: Kattan Michael W; Cuzick Jack; Fisher Gabrielle; Berney Daniel M; Oliver Tim; Foster Christopher S; Møller Henrik; Reuter Victor; Fearn Paul; Eastham James; Scardino Peter T;
Nomogram incorporating PSA level to predict cancer-specific survival for men with clinically localized prostate cancer managed without curative intent.
Cancer 2008;112(1):69-74.
-
2008: Attard G; Clark J; Ambroisine L; Fisher G; Kovacs G; Flohr P; Berney D; Foster C S; Fletcher A; Gerald W L; Moller H; Reuter V; De Bono J S; Scardino P; Cuzick J; Cooper C S;
Duplication of the fusion of TMPRSS2 to ERG sequences identifies fatal human prostate cancer.
Oncogene 2008;27(3):253-63.
-
2008: Vickers Andrew J; Cronin Angel M; Aus Gunnar; Pihl Carl-Gustav; Becker Charlotte; Pettersson Kim; Scardino Peter T; Hugosson Jonas; Lilja Hans
A panel of kallikrein markers can reduce unnecessary biopsy for prostate cancer: data from the European Randomized Study of Prostate Cancer Screening in Göteborg, Sweden.
BMC medicine 2008;6():19.
-
2008: Ulmert David; Cronin Angel M; Björk Thomas; O'Brien Matthew F; Scardino Peter T; Eastham James A; Becker Charlotte; Berglund Göran; Vickers Andrew J; Lilja Hans
Prostate-specific antigen at or before age 50 as a predictor of advanced prostate cancer diagnosed up to 25 years later: a case-control study.
BMC medicine 2008;6():6.
-
2007: Park Jason; Scardino Peter T
Surgeon's core values: legitimizing the team concept in surgery.
Nature clinical practice. Urology 2007;4(12):635.
-
2007: Zang Xingxing; Thompson R Houston; Al-Ahmadie Hikmat A; Serio Angel M; Reuter Victor E; Eastham James A; Scardino Peter T; Sharma Padmanee; Allison James P
B7-H3 and B7x are highly expressed in human prostate cancer and associated with disease spread and poor outcome.
Proceedings of the National Academy of Sciences of the United States of America 2007;104(49):19458-63.
-
2007: Kattan Michael W; Scardino Peter T
Evidence for the usefulness of nomograms.
Nature clinical practice. Urology 2007;4(12):638-9.
-
2007: Berney Daniel M; Fisher Gabrielle; Kattan Michael W; Oliver R Timothy D; Møller Henrik; Fearn Paul; Eastham James; Scardino Peter; Cuzick Jack; Reuter Victor E; Foster Christopher S;
Major shifts in the treatment and prognosis of prostate cancer due to changes in pathological diagnosis and grading.
BJU international 2007;100(6):1240-4.
-
2007: Eggener Scott E; Scardino Peter T; Carroll Peter R; Zelefsky Michael J; Sartor Oliver; Hricak Hedvig; Wheeler Thomas M; Fine Samson W; Trachtenberg John; Rubin Mark A; Ohori Mak; Kuroiwa Kentaro; Rossignol Michel; Abenhaim Lucien;
Focal therapy for localized prostate cancer: a critical appraisal of rationale and modalities.
The Journal of urology 2007;178(6):2260-7.
-
2007: Eastham James A; Kuroiwa Kentaro; Ohori Makoto; Serio Angel M; Gorbonos Alex; Maru Norio; Vickers Andrew J; Slawin Kevin M; Wheeler Thomas M; Reuter Victor E; Scardino Peter T
Prognostic significance of location of positive margins in radical prostatectomy specimens.
Urology 2007;70(5):965-9.
-
2007: Fine Samson W; Al-Ahmadie Hikmat A; Gopalan Anuradha; Tickoo Satish K; Scardino Peter T; Reuter Victor E
Anatomy of the anterior prostate and extraprostatic space: a contemporary surgical pathology analysis.
Advances in anatomic pathology 2007;14(6):401-7.
-
2007: Jang Thomas L; Yossepowitch Ofer; Bianco Fernando J; Scardino Peter T
Low risk prostate cancer in men under age 65: the case for definitive treatment.
Urologic oncology 2007;25(6):510-4.
-
2007: Vickers Andrew J; Ulmert David; Serio Angel M; Björk Thomas; Scardino Peter T; Eastham James A; Berglund Göran; Lilja Hans
The predictive value of prostate cancer biomarkers depends on age and time to diagnosis: towards a biologically-based screening strategy.
International journal of cancer. Journal international du cancer 2007;121(10):2212-7.
-
2007: Scardino Peter T
Are current staging systems for cancer serving us well?
Nature clinical practice. Urology 2007;4(10):517.
-
2007: Berney D M; Fisher G; Kattan M W; Oliver R T D; Møller H; Fearn P; Eastham J; Scardino P; Cuzick J; Reuter V E; Foster C S;
Pitfalls in the diagnosis of prostatic cancer: retrospective review of 1791 cases with clinical outcome.
Histopathology 2007;51(4):452-7.
-
2007: Li Rile; Erdamar Sibel; Dai Hong; Wheeler Thomas M; Frolov Anna; Scardino Peter T; Thompson Timothy C; Ayala Gustavo E
Forkhead protein FKHR and its phosphorylated form p-FKHR in human prostate cancer.
Human pathology 2007;38(10):1501-7.
-
2007: Touijer Karim; Kuroiwa Kentaro; Eastham James A; Vickers Andrew; Reuter Victor E; Scardino Peter T; Guillonneau Bertrand
Risk-adjusted analysis of positive surgical margins following laparoscopic and retropubic radical prostatectomy.
European urology 2007;52(4):1090-6.
-
2007: Ishii Junichiro; Ohori Makoto; Scardino Peter; Tsuboi Toshiki; Slawin Kevin; Wheeler Thomas
Significance of the craniocaudal distribution of cancer in radical prostatectomy specimens.
International journal of urology : official journal of the Japanese Urological Association 2007;14(9):817-21.
-
2007: Pucar Darko; Hricak Hedvig; Shukla-Dave Amita; Kuroiwa Kentaro; Drobnjak Marija; Eastham James; Scardino Peter T; Zelefsky Michael J
Clinically significant prostate cancer local recurrence after radiation therapy occurs at the site of primary tumor: magnetic resonance imaging and step-section pathology evidence.
International journal of radiation oncology, biology, physics 2007;69(1):62-9.
-
2007: Zelefsky Michael J; Kattan Michael W; Fearn Paul; Fearon Bertha L; Stasi Jason P; Shippy Alison M; Scardino Peter T
Pretreatment nomogram predicting ten-year biochemical outcome of three-dimensional conformal radiotherapy and intensity-modulated radiotherapy for prostate cancer.
Urology 2007;70(2):283-7.
-
2007: Scardino Peter T; Hay Alexandra M
Point of care testing: a welcome advance?
Nature clinical practice. Urology 2007;4(8):401.
-
2007: Vickers Andrew J; Bianco Fernando J; Serio Angel M; Eastham James A; Schrag Deborah; Klein Eric A; Reuther Alwyn M; Kattan Michael W; Pontes J Edson; Scardino Peter T
The surgical learning curve for prostate cancer control after radical prostatectomy.
Journal of the National Cancer Institute 2007;99(15):1171-7.
-
2007: Yossepowitch Ofer; Eggener Scott E; Bianco Fernando J; Carver Brett S; Serio Angel; Scardino Peter T; Eastham James A
Radical prostatectomy for clinically localized, high risk prostate cancer: critical analysis of risk assessment methods.
The Journal of urology 2007;178(2):493-9; discussion 499.
-
2007: Bjartell Anders S; Al-Ahmadie Hikmat; Serio Angel M; Eastham James A; Eggener Scott E; Fine Samson W; Udby Lene; Gerald William L; Vickers Andrew J; Lilja Hans; Reuter Victor E; Scardino Peter T
Association of cysteine-rich secretory protein 3 and beta-microseminoprotein with outcome after radical prostatectomy.
Clinical cancer research : an official journal of the American Association for Cancer Research 2007;13(14):4130-8.
-
2007: Scardino Peter T
A hazard surgeons need to address.
Nature clinical practice. Urology 2007;4(7):347.
-
2007: Cordon-Cardo Carlos; Kotsianti Angeliki; Verbel David A; Teverovskiy Mikhail; Capodieci Paola; Hamann Stefan; Jeffers Yusuf; Clayton Mark; Elkhettabi Faysal; Khan Faisal M; Sapir Marina; Bayer-Zubek Valentina; Vengrenyuk Yevgen; Fogarsi Stephen; Saidi Olivier; Reuter Victor E; Scher Howard I; Kattan Michael W; Bianco Fernando J; Wheeler Thomas M; Ayala Gustavo E; Scardino Peter T; Donovan Michael J
Improved prediction of prostate cancer recurrence through systems pathology.
The Journal of clinical investigation 2007;117(7):1876-83.
-
2007: Touijer Karim; Rabbani Farhang; Otero Javier Romero; Secin Fernando P; Eastham James A; Scardino Peter T; Guillonneau Bertrand
Standard versus limited pelvic lymph node dissection for prostate cancer in patients with a predicted probability of nodal metastasis greater than 1%.
The Journal of urology 2007;178(1):120-4.
-
2007: Eggener Scott E; Yossepowitch Ofer; Serio Angel M; Vickers Andrew J; Scardino Peter T; Eastham James A
Radical prostatectomy shortly after prostate biopsy does not affect operative difficulty or efficacy.
Urology 2007;69(6):1128-33.
-
2007: Stephenson Andrew J; Scardino Peter T; Kattan Michael W; Pisansky Thomas M; Slawin Kevin M; Klein Eric A; Anscher Mitchell S; Michalski Jeff M; Sandler Howard M; Lin Daniel W; Forman Jeffrey D; Zelefsky Michael J; Kestin Larry L; Roehrborn Claus G; Catton Charles N; DeWeese Theodore L; Liauw Stanley L; Valicenti Richard K; Kuban Deborah A; Pollack Alan
Predicting the outcome of salvage radiation therapy for recurrent prostate cancer after radical prostatectomy.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007;25(15):2035-41.
-
2007: Scardino Peter T
Intoxicated by technology: are we keeping our eyes on the prize?
Nature clinical practice. Urology 2007;4(5):231.
-
2007: Scardino Peter T
Prediction models in urology.
Nature clinical practice. Urology 2007;4(4):173.
-
2007: Hricak Hedvig; Choyke Peter L; Eberhardt Steven C; Leibel Steven A; Scardino Peter T
Imaging prostate cancer: a multidisciplinary perspective.
Radiology 2007;243(1):28-53.
-
2007: Huang William C; Kuroiwa Kentaro; Serio Angel M; Bianco Fernando J; Fine Samson W; Shayegan Bobby; Scardino Peter T; Eastham James A
The anatomical and pathological characteristics of irradiated prostate cancers may influence the oncological efficacy of salvage ablative therapies.
The Journal of urology 2007;177(4):1324-9; quiz 1591.
-
2007: Shukla-Dave Amita; Hricak Hedvig; Kattan Michael W; Pucar Darko; Kuroiwa Kentaro; Chen Hui-Ni; Spector Jessica; Koutcher Jason A; Zakian Kristen L; Scardino Peter T
The utility of magnetic resonance imaging and spectroscopy for predicting insignificant prostate cancer: an initial analysis.
BJU international 2007;99(4):786-93.
-
2007: Steuber Thomas; Vickers Andrew; Haese Alexander; Kattan Michael W; Eastham James A; Scardino Peter T; Huland Hartwig; Lilja Hans
Free PSA isoforms and intact and cleaved forms of urokinase plasminogen activator receptor in serum improve selection of patients for prostate cancer biopsy.
International journal of cancer. Journal international du cancer 2007;120(7):1499-504.
-
2007: Yossepowitch Ofer; Bianco Fernando J; Eggener Scott E; Eastham James A; Scher Howard I; Scardino Peter T
The natural history of noncastrate metastatic prostate cancer after radical prostatectomy.
European urology 2007;51(4):940-7; discussion 947-8.
-
2007: Baccala Angelo; Reuther Alwyn M; Bianco Fernando J; Scardino Peter T; Kattan Michael W; Klein Eric A
Complete resection of seminal vesicles at radical prostatectomy results in substantial long-term disease-free survival: multi-institutional study of 6740 patients.
Urology 2007;69(3):536-40.
-
2007: Bianco Fernando J; Mallah Kozhaya N; Korets Ruslan; Hricak Hedvig; Scardino Peter T; Kattan Michael W
Prostate volume measured preoperatively predicts for organ-confined disease in men with clinically localized prostate cancer.
Urology 2007;69(2):343-6.
-
2007: Lilja Hans; Vickers Andrew; Scardino Peter
Measurements of proteases or protease system components in blood to enhance prediction of disease risk or outcome in possible cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007;25(4):347-8.
-
2007: Secin Fernando P; Koppie Theresa M; Scardino Peter T; Eastham James A; Patel Manish; Bianco Fernando J; Tal Renaan; Mulhall John; Disa Joseph J; Cordeiro Peter G; Rabbani Farhang
Bilateral cavernous nerve interposition grafting during radical retropubic prostatectomy: Memorial Sloan-Kettering Cancer Center experience.
The Journal of urology 2007;177(2):664-8.
-
2007: Steuber Thomas; Vickers Andrew J; Serio Angel M; Vaisanen Ville; Haese Alexander; Pettersson Kim; Eastham James A; Scardino Peter T; Huland Hartwig; Lilja Hans
Comparison of free and total forms of serum human kallikrein 2 and prostate-specific antigen for prediction of locally advanced and recurrent prostate cancer.
Clinical chemistry 2007;53(2):233-40.
-
2007: Scardino Peter T
The responsible use of antibiotics for an elevated PSA level.
Nature clinical practice. Urology 2007;4(1):1.
-
2007: Wang Liang; Zhang Jingbo; Schwartz Lawrence H; Eisenberg Halley; Ishill Nicole M; Moskowitz Chaya S; Scardino Peter; Hricak Hedvig
Incremental value of multiplanar cross-referencing for prostate cancer staging with endorectal MRI.
AJR. American journal of roentgenology 2007;188(1):99-104.
-
2007: Wang Liang; Hricak Hedvig; Kattan Michael W; Chen Hui Ni; Kuroiwa Kentaro; Eisenberg Halley F; Scardino Peter T
Prediction of seminal vesicle invasion in prostate cancer: incremental value of adding endorectal MR imaging to the Kattan nomogram.
Radiology 2007;242(1):182-8.
-
2006: Koppie Theresa M; Bianco Fernando J; Kuroiwa Kentaro; Reuter Victor E; Guillonneau Bertrand; Eastham James A; Scardino Peter T
The clinical features of anterior prostate cancers.
BJU international 2006;98(6):1167-71.
-
2006: Cuzick J; Fisher G; Kattan M W; Berney D; Oliver T; Foster C S; Møller H; Reuter V; Fearn P; Eastham J; Scardino P;
Long-term outcome among men with conservatively treated localised prostate cancer.
British journal of cancer 2006;95(9):1186-94.
-
2006: Ryan Charles J; Smith Alex; Lal Priti; Satagopan Jaya; Reuter Victor; Scardino Peter; Gerald William; Scher Howard I
Persistent prostate-specific antigen expression after neoadjuvant androgen depletion: an early predictor of relapse or incomplete androgen suppression.
Urology 2006;68(4):834-9.
-
2006: Bochner Bernard H; Scardino Peter T
Multimodal therapy for urologic cancers.
Nature clinical practice. Urology 2006;3(9):453.
-
2006: Huang William C; Levey Andrew S; Serio Angel M; Snyder Mark; Vickers Andrew J; Raj Ganesh V; Scardino Peter T; Russo Paul
Chronic kidney disease after nephrectomy in patients with renal cortical tumours: a retrospective cohort study.
The lancet oncology 2006;7(9):735-40.
-
2006: Donohue John F; Bianco Fernando J; Kuroiwa Kentaro; Vickers Andrew J; Wheeler Thomas M; Scardino Peter T; Reuter Victor A; Eastham James A
Poorly differentiated prostate cancer treated with radical prostatectomy: long-term outcome and incidence of pathological downgrading.
The Journal of urology 2006;176(3):991-5.
-
2006: Stephenson Andrew J; Kattan Michael W; Eastham James A; Dotan Zohar A; Bianco Fernando J; Lilja Hans; Scardino Peter T
Defining biochemical recurrence of prostate cancer after radical prostatectomy: a proposal for a standardized definition.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2006;24(24):3973-8.
-
2006: Scardino Peter T
Surgery in elderly cancer patients.
Nature clinical practice. Urology 2006;3(8):397.
-
2006: Huang William C; Kwon Eric O; Scardino Peter T; Eastham James A
Radical prostatectomy in patients infected with human immunodeficiency virus.
BJU international 2006;98(2):303-7.
-
2006: Carver Brett S; Bianco Fernando J; Scardino Peter T; Eastham James A
Long-term outcome following radical prostatectomy in men with clinical stage T3 prostate cancer.
The Journal of urology 2006;176(2):564-8.
-
2006: Solomon Julie; Hay Alexandra M; Scardino Peter T
Peer review: the importance of quality control.
Nature clinical practice. Urology 2006;3(7):345.
-
2006: Secin Fernando P; Bianco Fernando J; Vickers Andrew J; Reuter Victor; Wheeler Thomas; Fearn Paul A; Eastham James A; Scardino Peter T
Cancer-specific survival and predictors of prostate-specific antigen recurrence and survival in patients with seminal vesicle invasion after radical prostatectomy.
Cancer 2006;106(11):2369-75.
-
2006: Akin Oguz; Sala Evis; Moskowitz Chaya S; Kuroiwa Kentaro; Ishill Nicole M; Pucar Darko; Scardino Peter T; Hricak Hedvig
Transition zone prostate cancers: features, detection, localization, and staging at endorectal MR imaging.
Radiology 2006;239(3):784-92.
-
2006: Stephenson Andrew J; Scardino Peter T; Eastham James A; Bianco Fernando J; Dotan Zohar A; Fearn Paul A; Kattan Michael W
Preoperative nomogram predicting the 10-year probability of prostate cancer recurrence after radical prostatectomy.
Journal of the National Cancer Institute 2006;98(10):715-7.
-
2006: Scardino Peter T; Bianco Fernando
The role of outcomes research in improving patient care.
Nature clinical practice. Urology 2006;3(5):233.
-
2006: Touijer Karim; Kuroiwa Kentaro; Vickers Andrew; Reuter Victor E; Hricak Hedwig; Scardino Peter T; Guillonneau Bertrand
Impact of a multidisciplinary continuous quality improvement program on the positive surgical margin rate after laparoscopic radical prostatectomy.
European urology 2006;49(5):853-8.
-
2006: Shabsigh Ahmad; Scardino Peter T
The urologist and medical imaging.
Nature clinical practice. Urology 2006;3(4):175.
-
2006: Masterson Timothy A; Bianco Fernando J; Vickers Andrew J; DiBlasio Christopher J; Fearn Paul A; Rabbani Farhang; Eastham James A; Scardino Peter T
The association between total and positive lymph node counts, and disease progression in clinically localized prostate cancer.
The Journal of urology 2006;175(4):1320-4; discussion 1324-5.
-
2006: Wang Liang; Hricak Hedvig; Kattan Michael W; Schwartz Lawrence H; Eberhardt Steven C; Chen Hui-Ni; Scardino Peter T
Combined endorectal and phased-array MRI in the prediction of pelvic lymph node metastasis in prostate cancer.
AJR. American journal of roentgenology 2006;186(3):743-8.
-
2006: Lopez-Corona Ernesto; Ohori Makoto; Wheeler Thomas M; Reuter Victor E; Scardino Peter T; Kattan Michael W; Eastham James A
Prostate cancer diagnosed after repeat biopsies have a favorable pathological outcome but similar recurrence rate.
The Journal of urology 2006;175(3 Pt 1):923-7; discussion 927-8.
-
2006: Sala Evis; Akin Oguz; Moskowitz Chaya S; Eisenberg Halley F; Kuroiwa Kentaro; Ishill Nicole M; Rajashanker Balashanmugam; Scardino Peter T; Hricak Hedvig
Endorectal MR imaging in the evaluation of seminal vesicle invasion: diagnostic accuracy and multivariate feature analysis.
Radiology 2006;238(3):929-37.
-
2006: Steuber Thomas; Vickers Andrew J; Haese Alexander; Becker Charlotte; Pettersson Kim; Chun Felix K-H; Kattan Michael W; Eastham James A; Scardino Peter T; Huland Hartwig; Lilja Hans
Risk assessment for biochemical recurrence prior to radical prostatectomy: significant enhancement contributed by human glandular kallikrein 2 (hK2) and free prostate specific antigen (PSA) in men with moderate PSA-elevation in serum.
International journal of cancer. Journal international du cancer 2006;118(5):1234-40.
-
2006: Scardino Peter T
Supporting the support groups.
Nature clinical practice. Urology 2006;3(2):59.
-
2006: Li Rile; Wheeler Thomas M; Dai Hong; Sayeeduddin Mohammad; Scardino Peter T; Frolov Anna; Ayala Gustavo E
Biological correlates of p27 compartmental expression in prostate cancer.
The Journal of urology 2006;175(2):528-32.
-
2006: Vickers Andrew J; Bianco Fernando J; Boorjian Stephen; Scardino Peter T; Eastham James A
Does a delay between diagnosis and radical prostatectomy increase the risk of disease recurrence?
Cancer 2006;106(3):576-80.
-
2006: Wang Liang; Hricak Hedvig; Kattan Michael W; Chen Hui-Ni; Scardino Peter T; Kuroiwa Kentaro
Prediction of organ-confined prostate cancer: incremental value of MR imaging and MR spectroscopic imaging to staging nomograms.
Radiology 2006;238(2):597-603.
-
2006: Mullerad Michael; Donohue John F; Li Philip S; Scardino Peter T; Mulhall John P
Functional sequelae of cavernous nerve injury in the rat: is there model dependency.
The journal of sexual medicine 2006;3(1):77-83.
-
2006: Mullerad Michael; Eisenberg David P; Akhurst Timothy J; Adusumilli Prasad S; Riedl Christopher C; Bhargava Amit; Gonen Mithat; Finn Ronald; Scardino Peter T; Fong Yuman
Use of positron emission tomography to target prostate cancer gene therapy by oncolytic herpes simplex virus.
Molecular imaging and biology : MIB : the official publication of the Academy of Molecular Imaging 2006;8(1):30-5.
-
2005: Scardino Peter T
Clinical research and the financial markets: opportunities and risks.
Nature clinical practice. Urology 2005;2(12):573.
-
2005: Tsuboi Toshiki; Ohori Makoto; Kuroiwa Kentaro; Reuter Victor E; Kattan Michael W; Eastham James A; Scardino Peter T
Is intraoperative frozen section analysis an efficient way to reduce positive surgical margins?
Urology 2005;66(6):1287-91.
-
2005: Karakiewicz Pierre I; Eastham James A; Graefen Markus; Cagiannos Ilias; Stricker Phillip D; Klein Eric; Cangiano Thomas; Schröder Fritz H; Scardino Peter T; Kattan Michael W
Prognostic impact of positive surgical margins in surgically treated prostate cancer: multi-institutional assessment of 5831 patients.
Urology 2005;66(6):1245-50.
-
2005: Mullerad Michael; Hricak Hedvig; Kuroiwa Kentaro; Pucar Darko; Chen Hui-Ni; Kattan Michael W; Scardino Peter T
Comparison of endorectal magnetic resonance imaging, guided prostate biopsy and digital rectal examination in the preoperative anatomical localization of prostate cancer.
The Journal of urology 2005;174(6):2158-63.
-
2005: Hay Alexandra M; Scardino Peter T
Nature Clinical Practice Urology: one year on.
Nature clinical practice. Urology 2005;2(11):517.
-
2005: Scardino Peter
Update: NCCN prostate cancer Clinical Practice Guidelines.
Journal of the National Comprehensive Cancer Network : JNCCN 2005;3 Suppl 1():S29-33.
-
2005: Bianco Fernando J; Scardino Peter T; Eastham James A
Radical prostatectomy: long-term cancer control and recovery of sexual and urinary function ("trifecta").
Urology 2005;66(5 Suppl):83-94.
-
2005: Stephenson Andrew J; Scardino Peter T; Eastham James A; Bianco Fernando J; Dotan Zohar A; DiBlasio Christopher J; Reuther Alwyn; Klein Eric A; Kattan Michael W
Postoperative nomogram predicting the 10-year probability of prostate cancer recurrence after radical prostatectomy.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(28):7005-12.
-
2005: Boorjian Stephen A; Bianco Fernando J; Scardino Peter T; Eastham James A
Does the time from biopsy to surgery affect biochemical recurrence after radical prostatectomy?
BJU international 2005;96(6):773-6.
-
2005: Scardino Peter T
New technology and the changing world of cancer.
Nature clinical practice. Urology 2005;2(9):403.
-
2005: Befort Christie A; Zelefsky Michael J; Scardino Peter T; Borrayo Evelinn; Giesler R Brian; Kattan Michael W
A measure of health-related quality of life among patients with localized prostate cancer: results from ongoing scale development.
Clinical prostate cancer 2005;4(2):100-8.
-
2005: Masterson Timothy A; Stephenson Andrew J; Scardino Peter T; Eastham James A
Recovery of erectile function after salvage radical prostatectomy for locally recurrent prostate cancer after radiotherapy.
Urology 2005;66(3):623-6.
-
2005: Swindle Peter; Eastham James A; Ohori Makoto; Kattan Michael W; Wheeler Thomas; Maru Norio; Slawin Kevin; Scardino Peter T
Do margins matter? The prognostic significance of positive surgical margins in radical prostatectomy specimens.
The Journal of urology 2005;174(3):903-7.
-
2005: Scardino Peter T
How close are we to preventing prostate cancer?
Nature clinical practice. Urology 2005;2(8):355.
-
2005: Pucar Darko; Shukla-Dave Amita; Hricak Hedvig; Moskowitz Chaya S; Kuroiwa Kentaro; Olgac Semra; Ebora Lanie E; Scardino Peter T; Koutcher Jason A; Zakian Kristen L
Prostate cancer: correlation of MR imaging and MR spectroscopy with pathologic findings after radiation therapy-initial experience.
Radiology 2005;236(2):545-53.
-
2005: Schöder Heiko; Herrmann Ken; Gönen Mithat; Hricak Hedvig; Eberhard Stephen; Scardino Peter; Scher Howard I; Larson Steven M
2-[18F]fluoro-2-deoxyglucose positron emission tomography for the detection of disease in patients with prostate-specific antigen relapse after radical prostatectomy.
Clinical cancer research : an official journal of the American Association for Cancer Research 2005;11(13):4761-9.
-
2005: Kilgo Matthew S; Howard Michael A; Kaplan Gordon; Rabbani Farhang; Scardino Peter T; Cordeiro Peter G
Evaluation of genitofemoral nerve donor site morbidity after radical prostatectomy.
Annals of plastic surgery 2005;55(1):57-61; discussion 61-2.
-
2005: Stephenson Andrew J; Smith Alex; Kattan Michael W; Satagopan Jaya; Reuter Victor E; Scardino Peter T; Gerald William L
Integration of gene expression profiling and clinical variables to predict prostate carcinoma recurrence after radical prostatectomy.
Cancer 2005;104(2):290-8.
-
2005: Saranchuk Jeffery W; Kattan Michael W; Elkin Elena; Touijer A Karim; Scardino Peter T; Eastham James A
Achieving optimal outcomes after radical prostatectomy.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(18):4146-51.
-
2005: Bianco Fernando J; Scardino Peter T; Stephenson Andrew J; Diblasio Christopher J; Fearn Paul A; Eastham James A
Long-term oncologic results of salvage radical prostatectomy for locally recurrent prostate cancer after radiotherapy.
International journal of radiation oncology, biology, physics 2005;62(2):448-53.
-
2005: Bianco Fernando J; Riedel Elyn R; Begg Colin B; Kattan Michael W; Scardino Peter T
Variations among high volume surgeons in the rate of complications after radical prostatectomy: further evidence that technique matters.
The Journal of urology 2005;173(6):2099-103.
-
2005: Karakiewicz Pierre I; Benayoun Serge; Kattan Michael W; Perrotte Paul; Valiquette Luc; Scardino Peter T; Cagiannos Ilias; Heinzer Hans; Tanguay Simon; Aprikian Armen G; Huland Hartwig; Graefen Markus
Development and validation of a nomogram predicting the outcome of prostate biopsy based on patient age, digital rectal examination and serum prostate specific antigen.
The Journal of urology 2005;173(6):1930-4.
-
2005: Beekman Kathleen; Morris Michael; Slovin Susan; Heller Glenn; Wilton Andrew; Bianco Fernando; Scardino Peter T; Scher Howard I
Androgen deprivation for minimal metastatic disease: threshold for achieving undetectable prostate-specific antigen.
Urology 2005;65(5):947-52.
-
2005: Mallah Kozhaya N; DiBlasio Christopher J; Rhee Audrey C; Scardino Peter T; Kattan Michael W
Body mass index is weakly associated with, and not a helpful predictor of, disease progression in men with clinically localized prostate carcinoma treated with radical prostatectomy.
Cancer 2005;103(10):2030-4.
-
2005: Scardino Peter T; Farley Suzanne J
The physician and conflict of interest.
Nature clinical practice. Urology 2005;2(3):113.
-
2005: Dotan Zohar A; Bianco Fernando J; Rabbani Farhang; Eastham James A; Fearn Paul; Scher Howard I; Kelly Kevin W; Chen Hui-Ni; Schöder Heiko; Hricak Hedvig; Scardino Peter T; Kattan Michael W
Pattern of prostate-specific antigen (PSA) failure dictates the probability of a positive bone scan in patients with an increasing PSA after radical prostatectomy.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(9):1962-8.
-
2005: Zakian Kristen L; Sircar Kanishka; Hricak Hedvig; Chen Hui-Ni; Shukla-Dave Amita; Eberhardt Steven; Muruganandham Manickam; Ebora Lanie; Kattan Michael W; Reuter Victor E; Scardino Peter T; Koutcher Jason A
Correlation of proton MR spectroscopic imaging with gleason score based on step-section pathologic analysis after radical prostatectomy.
Radiology 2005;234(3):804-14.
-
2005: Carver Brett S; Kattan Michael W; Scardino Peter T; Eastham James A
Gleason grade remains an important prognostic predictor in men diagnosed with prostate cancer while on finasteride therapy.
BJU international 2005;95(4):509-12.
-
2005: Yanke Brent V; Gonen Mithat; Scardino Peter T; Kattan Michael W
Validation of a nomogram for predicting positive repeat biopsy for prostate cancer.
The Journal of urology 2005;173(2):421-4.
-
2005: Scardino Peter T
Continuing refinements in radical prostatectomy: more evidence that technique matters.
The Journal of urology 2005;173(2):338-9.
-
2005: Scardino Peter T; Fearn Paul
Information systems for urologists: the message from Mansoura, Egypt.
Nature clinical practice. Urology 2005;2(1):1.
-
2005: Chang Shine; Erdman John W; Clinton Steven K; Vadiveloo Maya; Strom Sara S; Yamamura Yuko; Duphorne Cherie M; Spitz Margaret R; Amos Christopher I; Contois John H; Gu Xiangjun; Babaian Richard J; Scardino Peter T; Hursting Stephen D
Relationship between plasma carotenoids and prostate cancer.
Nutrition and cancer 2005;53(2):127-34.
-
2004: Scardino Peter T
Technique matters.
Nature clinical practice. Urology 2004;1(2):55.
-
2004: Pucar Darko; Koutcher Jason A; Shah Ankoor; Dyke John P; Schwartz Lawrence; Thaler Howard; Kurhanewicz John; Scardino Peter T; Kelly W Kevin; Hricak Hedvig; Zakian Kristen L
Preliminary assessment of magnetic resonance spectroscopic imaging in predicting treatment outcome in patients with prostate cancer at high risk for relapse.
Clinical prostate cancer 2004;3(3):174-81.
-
2004: Stephenson Andrew J; Slawin Kevin M; Bianco Fernando J; Scardino Peter T
Perspectives on the natural history of recurrent prostate cancer after radical prostatectomy, based on the response to salvage radiotherapy.
BJU international 2004;94(9):1210-2.
-
2004: Stephenson Andrew J; Scardino Peter T; Bianco Fernando J; DiBlasio Christopher J; Fearn Paul A; Eastham James A
Morbidity and functional outcomes of salvage radical prostatectomy for locally recurrent prostate cancer after radiation therapy.
The Journal of urology 2004;172(6 Pt 1):2239-43.
-
2004: Bianco Fernando J; Kattan Michael W; Scardino Peter T
PSA velocity and prostate cancer.
The New England journal of medicine 2004;351(17):1800-2; author reply 1800-2.
-
2004: Ayala Gustavo; Thompson Timothy; Yang Guang; Frolov Anna; Li Rile; Scardino Peter; Ohori Makoto; Wheeler Thomas; Harper Wade
High levels of phosphorylated form of Akt-1 in prostate cancer and non-neoplastic prostate tissues are strong predictors of biochemical recurrence.
Clinical cancer research : an official journal of the American Association for Cancer Research 2004;10(19):6572-8.
-
2004: Stephenson Andrew J; Scardino Peter T; Bianco Fernando J; Eastham James A
Salvage therapy for locally recurrent prostate cancer after external beam radiotherapy.
Current treatment options in oncology 2004;5(5):357-65.
-
2004: Kikuchi Eiji; Scardino Peter T; Wheeler Thomas M; Slawin Kevin M; Ohori Makoto
Is tumor volume an independent prognostic factor in clinically localized prostate cancer?
The Journal of urology 2004;172(2):508-11.
-
2004: Wang Liang; Mullerad Michael; Chen Hui-Ni; Eberhardt Steven C; Kattan Michael W; Scardino Peter T; Hricak Hedvig
Prostate cancer: incremental value of endorectal MR imaging findings for prediction of extracapsular extension.
Radiology 2004;232(1):133-9.
-
2004: Mullerad Michael; Hricak Hedvig; Wang Liang; Chen Hui-Ni; Kattan Michael W; Scardino Peter T
Prostate cancer: detection of extracapsular extension by genitourinary and general body radiologists at MR imaging.
Radiology 2004;232(1):140-6.
-
2004: Hricak Hedvig; Wang Liang; Wei David C; Coakley Fergus V; Akin Oguz; Reuter Victor E; Gonen Mithat; Kattan Michael W; Onyebuchi Chinyere N; Scardino Peter T
The role of preoperative endorectal magnetic resonance imaging in the decision regarding whether to preserve or resect neurovascular bundles during radical retropubic prostatectomy.
Cancer 2004;100(12):2655-63.
-
2004: Shukla-Dave Amita; Hricak Hedvig; Eberhardt Steven C; Olgac Semra; Muruganandham Manickam; Scardino Peter T; Reuter Victor E; Koutcher Jason A; Zakian Kristen L
Chronic prostatitis: MR imaging and 1H MR spectroscopic imaging findings--initial observations.
Radiology 2004;231(3):717-24.
-
2004: Ohori Makoto; Kattan Michael W; Koh Hideshige; Maru Norio; Slawin Kevin M; Shariat Shahrokh; Muramoto Masatoshi; Reuter Victor E; Wheeler Thomas M; Scardino Peter T
Predicting the presence and side of extracapsular extension: a nomogram for staging prostate cancer.
The Journal of urology 2004;171(5):1844-9; discussion 1849.
-
2004: Sella Tamar; Schwartz Lawrence H; Swindle Peter W; Onyebuchi Chinyere N; Scardino Peter T; Scher Howard I; Hricak Hedvig
Suspected local recurrence after radical prostatectomy: endorectal coil MR imaging.
Radiology 2004;231(2):379-85.
-
2004: Patel Manish I; DeConcini Dino T; Lopez-Corona Ernesto; Ohori Makato; Wheeler Thomas; Scardino Peter T
An analysis of men with clinically localized prostate cancer who deferred definitive therapy.
The Journal of urology 2004;171(4):1520-4.
-
2004: Stephenson Andrew J; Shariat Shahrokh F; Zelefsky Michael J; Kattan Michael W; Butler E Brian; Teh Bin S; Klein Eric A; Kupelian Patrick A; Roehrborn Claus G; Pistenmaa David A; Pacholke Heather D; Liauw Stanley L; Katz Matthew S; Leibel Steven A; Scardino Peter T; Slawin Kevin M
Salvage radiotherapy for recurrent prostate cancer after radical prostatectomy.
JAMA : the journal of the American Medical Association 2004;291(11):1325-32.
-
2004: Ohori Makoto; Kattan Michael; Scardino Peter T; Wheeler Thomas M
Radical prostatectomy for carcinoma of the prostate.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2004;17(3):349-59.
-
2004: Li Rile; Younes Mamoun; Wheeler Thomas M; Scardino Peter; Ohori Makato; Frolov Anna; Ayala Gustavo
Expression of vascular endothelial growth factor receptor-3 (VEGFR-3) in human prostate.
The Prostate 2004;58(2):193-9.
-
2004: Hall R E; Horsfall D J; Stahl J; Vivekanandan S; Ricciardelli C; Stapleton A M F; Scardino P T; Neufing P; Tilley Wayne D
Apolipoprotein-D: a novel cellular marker for HGPIN and prostate cancer.
The Prostate 2004;58(2):103-8.
-
2004: Konety Badrinath R; Eastham James A; Reuter Vicor E; Scardino Peter T; Donat S Machele; Dalbagni Guido; Russo Paul; Herr Harry W; Schwartz Larry; Kantoff Philip W; Scher Howard; Kelly W Kevin
Feasibility of radical prostatectomy after neoadjuvant chemohormonal therapy for patients with high risk or locally advanced prostate cancer: results of a phase I/II study.
The Journal of urology 2004;171(2 Pt 1):709-13.
-
2004: Cagiannos Ilias; Karakiewicz Pierre; Graefen Markus; Eastham James A; Ohori Makoto; Rabbani Farhang; Reuter Victor; Wheeler Thomas; Kupelian Patrick; Klein Eric; Huland Hartwig; Hammerer Peter G; Erbersdobler Andreas; Schroeder Fritz; Wildhagen Mark; Quinn David I; Henshall Susan M; Grygiel John J; Sutherland Robert L; Stricker Phillip D; Morash Christopher G; Scardino Peter T; Kattan Michael W
Is year of radical prostatectomy a predictor of outcome in prostate cancer?
The Journal of urology 2004;171(2 Pt 1):692-6.
-
2004: Holzbeierlein Jeff; Lal Priti; LaTulippe Eva; Smith Alex; Satagopan Jaya; Zhang Liying; Ryan Charles; Smith Steve; Scher Howard; Scardino Peter; Reuter Victor; Gerald William L
Gene expression analysis of human prostate carcinoma during hormonal therapy identifies androgen-responsive genes and mechanisms of therapy resistance.
The American journal of pathology 2004;164(1):217-27.
-
2004: Graefen Markus; Ohori Makoto; Karakiewicz Pierre I; Cagiannos Ilias; Hammerer Peter G; Haese Alexander; Erbersdobler Andreas; Henke Rolf-Peter; Huland Hartwig; Wheeler Thomas M; Slawin Kevin; Scardino Peter T; Kattan Michael W
Assessment of the enhancement in predictive accuracy provided by systematic biopsy in predicting outcome for clinically localized prostate cancer.
The Journal of urology 2004;171(1):200-3.
-
2003: Kattan Michael W; Zelefsky Michael J; Kupelian Patrick A; Cho Daniel; Scardino Peter T; Fuks Zvi; Leibel Steven A
Pretreatment nomogram that predicts 5-year probability of metastasis following three-dimensional conformal radiation therapy for localized prostate cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2003;21(24):4568-71.
-
2003: Eastham James A; Kattan Michael W; Riedel Elyn; Begg Colin B; Wheeler Thomas M; Gerigk Claudia; Gonen Mithat; Reuter Victor; Scardino Peter T
Variations among individual surgeons in the rate of positive surgical margins in radical prostatectomy specimens.
The Journal of urology 2003;170(6 Pt 1):2292-5.
-
2003: Cagiannos Ilias; Karakiewicz Pierre; Eastham James A; Ohori Makato; Rabbani Farhang; Gerigk Claudia; Reuter Victor; Graefen Markus; Hammerer Peter G; Erbersdobler Andreas; Huland Hartwig; Kupelian Patrick; Klein Eric; Quinn David I; Henshall Susan M; Grygiel John J; Sutherland Robert L; Stricker Phillip D; Morash Christopher G; Scardino Peter T; Kattan Michael W
A preoperative nomogram identifying decreased risk of positive pelvic lymph nodes in patients with prostate cancer.
The Journal of urology 2003;170(5):1798-803.
-
2003: Kattan Michael W; Eastham James A; Wheeler Thomas M; Maru Norio; Scardino Peter T; Erbersdobler Andreas; Graefen Markus; Huland Hartwig; Koh Hideshige; Shariat Shahrokh F; Slawin Kevin M; Ohori Makoto
Counseling men with prostate cancer: a nomogram for predicting the presence of small, moderately differentiated, confined tumors.
The Journal of urology 2003;170(5):1792-7.
-
2003: Ayala Gustavo; Tuxhorn Jennifer A; Wheeler Thomas M; Frolov Anna; Scardino Peter T; Ohori Makoto; Wheeler Marcus; Spitler Jeffrey; Rowley David R
Reactive stroma as a predictor of biochemical-free recurrence in prostate cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2003;9(13):4792-801.
-
2003: Di Blasio Christopher J; Rhee Audrey C; Cho Daniel; Scardino Peter T; Kattan Michael W
Predicting clinical end points: treatment nomograms in prostate cancer.
Seminars in oncology 2003;30(5):567-86.
-
2003: Koh Hideshige; Kattan Michael W; Scardino Peter T; Suyama Kazuho; Maru Norio; Slawin Kevin; Wheeler Thomas M; Ohori Makoto
A nomogram to predict seminal vesicle invasion by the extent and location of cancer in systematic biopsy results.
The Journal of urology 2003;170(4 Pt 1):1203-8.
-
2003: Lopez-Corona Ernesto; Ohori Makoto; Scardino Peter T; Reuter Victor E; Gonen Mithat; Kattan Michael W
A nomogram for predicting a positive repeat prostate biopsy in patients with a previous negative biopsy session.
The Journal of urology 2003;170(4 Pt 1):1184-8; discussion 1188.
-
2003: Eschwège P; Ferlicot S; Droupy S; Ba N; Conti M; Loric S; Coindard G; Denis I; Ferretti L; Cornelius A; Legrand A; Bedossa P; Benoît G; Jardin A; Scardino P
A histopathologic investigation of PGE(2) pathways as predictors of proliferation and invasion in urothelial carcinomas of the bladder.
European urology 2003;44(4):435-41.
-
2003: Zakian Kristen L; Eberhardt Steven; Hricak Hedvig; Shukla-Dave Amita; Kleinman Shanon; Muruganandham Manickam; Sircar Kanishka; Kattan Michael W; Reuter Victor E; Scardino Peter T; Koutcher Jason A
Transition zone prostate cancer: metabolic characteristics at 1H MR spectroscopic imaging--initial results.
Radiology 2003;229(1):241-7.
-
2003: Kattan Michael W; Shariat Shahrokh F; Andrews Ben; Zhu Kuichun; Canto Eduardo; Matsumoto Kazumasa; Muramoto Masatoshi; Scardino Peter T; Ohori Makoto; Wheeler Thomas M; Slawin Kevin M
The addition of interleukin-6 soluble receptor and transforming growth factor beta1 improves a preoperative nomogram for predicting biochemical progression in patients with clinically localized prostate cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2003;21(19):3573-9.
-
2003: Shariat Shahrokh F; Roudier Martine P; Wilcox George E; Kattan Michael W; Scardino Peter T; Vessella Robert L; Erdamar Sibel; Nguyen Cuong; Wheeler Thomas M; Slawin Kevin M
Comparison of immunohistochemistry with reverse transcription-PCR for the detection of micrometastatic prostate cancer in lymph nodes.
Cancer research 2003;63(15):4662-70.
-
2003: Li Rile; Younes Mamoun; Frolov Anna; Wheeler Thomas M; Scardino Peter; Ohori Makoto; Ayala Gustavo
Expression of neutral amino acid transporter ASCT2 in human prostate.
Anticancer research 2003;23(4):3413-8.
-
2003: Aleman Michael; Karakiewicz Pierre I; Kupelian Patrick; Kattan Michael W; Graefen Markus; Cagiannos Ilias; Eastham James; Scardino Peter T; Huland Hartwig; Klein Eric A
Age and PSA predict likelihood of organ-confined disease in men presenting with PSA less than 10 ng/mL: implications for screening.
Urology 2003;62(1):70-4.
-
2003: Scardino Peter T
The prevention of prostate cancer--the dilemma continues.
The New England journal of medicine 2003;349(3):297-9.
-
2003: Bianco Fernando J; Kattan Michael W; Scardino Peter T; Powell Isaac J; Pontes J Edson; Wood David P
Radical prostatectomy nomograms in black American men: accuracy and applicability.
The Journal of urology 2003;170(1):73-6; discussion 76-7.
-
2003: Yossepowitch Ofer; Trabulsi Edouard J; Kattan Michael W; Scardino Peter T
Predictive factors in prostate cancer: implications for decision making.
Cancer investigation 2003;21(3):465-80.
-
2003: Eastham James A; DiBlasio Christopher J; Scardino Peter T
Salvage radical prostatectomy for recurrence of prostate cancer after radiation therapy.
Current urology reports 2003;4(3):211-5.
-
2003: Eastham James A; Riedel Elyn; Scardino Peter T; Shike Moshe; Fleisher Martin; Schatzkin Arthur; Lanza Elaine; Latkany Lianne; Begg Colin B;
Variation of serum prostate-specific antigen levels: an evaluation of year-to-year fluctuations.
JAMA : the journal of the American Medical Association 2003;289(20):2695-700.
-
2003: Graefen M; Augustin H; Karakiewicz P I; Hammerer P G; Haese A; Palisaar J; Fernandez S; Noldus J; Erbersdobler A; Cagiannos I; Scardino P T; Kattan M W; Huland H
[Can nomograms derived in the U.S. applied to German patients? A study about the validation of preoperative nomograms predicting the risk of recurrence after radical prostatectomy]
Der Urologe. Ausg. A 2003;42(5):685-92.
-
2003: Swindle Peter W; Kattan Michael W; Scardino Peter T
Markers and meaning of primary treatment failure.
The Urologic clinics of North America 2003;30(2):377-401.
-
2003: Shariat Shahrokh F; Kattan Michael W; Erdamar Sibel; Nguyen Cuong; Scardino Peter T; Spencer David M; Wheeler Thomas M; Slawin Kevin M
Detection of clinically significant, occult prostate cancer metastases in lymph nodes using a splice variant-specific rt-PCR assay for human glandular kallikrein.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2003;21(7):1223-31.
-
2003: Ohori Makoto; Kattan Michael W; Utsunomiya Takuji; Suyama Kazuho; Scardino Peter T; Wheeler Thomas M
Do impalpable stage T1c prostate cancers visible on ultrasound differ from those not visible?
The Journal of urology 2003;169(3):964-8.
-
2003: Scherr Douglas; Swindle Peter W; Scardino Peter T;
National Comprehensive Cancer Network guidelines for the management of prostate cancer.
Urology 2003;61(2 Suppl 1):14-24.
-
2003: Karakiewicz Pierre I; Kattan Michael W; Tanguay Simon; Elhilali Mostafa M; Bazinet Michel; Scardino Peter T; Aprikian Armen G
Cross-cultural validation of the UCLA prostate cancer index.
Urology 2003;61(2):302-7.
-
2003: Begg Colin B; Scardino Peter T
Taking stock of volume-outcome studies.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2003;21(3):393-4.
-
2003: Haese Alexander; Graefen Markus; Becker Charlotte; Noldus Joachin; Katz Jared; Cagiannos Ilias; Kattan Michael; Scardino Peter T; Huland Edith; Huland Hartwig; Lilja Hans
The role of human glandular kallikrein 2 for prediction of pathologically organ confined prostate cancer.
The Prostate 2003;54(3):181-6.
-
2003: Ross Phillip L; Littenberg Benjamin; Fearn Paul; Scardino Peter T; Karakiewicz Pierre I; Kattan Michael W
Paper standard gamble: a paper-based measure of standard gamble utility for current health.
International journal of technology assessment in health care 2003;19(1):135-47.
-
2002: Vicini Frank A; Martinez Alvaro; Hanks Gerald; Hanlon Alex; Miles Brian; Kernan Ken; Beyers David; Ragde Haakon; Forman Jeffrey; Fontanesi James; Kestin Larry; Kovacs Gyorgy; Denis Louis; Slawin Kevin; Scardino Peter
An interinstitutional and interspecialty comparison of treatment outcome data for patients with prostate carcinoma based on predefined prognostic categories and minimum follow-up.
Cancer 2002;95(10):2126-35.
-
2002: Yossepowitch Ofer; Sircar Kanishka; Scardino Peter T; Ohori Makoto; Kattan Michael W; Wheeler Thomas M; Reuter Victor E
Bladder neck involvement in pathological stage pT4 radical prostatectomy specimens is not an independent prognostic factor.
The Journal of urology 2002;168(5):2011-5.
-
2002: Cozzi Paul J; Burke Peter B; Bhargav Amit; Heston Warren D W; Huryk Bob; Scardino Peter T; Fong Yuman
Oncolytic viral gene therapy for prostate cancer using two attenuated, replication-competent, genetically engineered herpes simplex viruses.
The Prostate 2002;53(2):95-100.
-
2002: Kattan Michael W; Scardino Peter T
Prediction of progression: nomograms of clinical utility.
Clinical prostate cancer 2002;1(2):90-6.
-
2002: Ohori Makoto; Scardino Peter T
Localized prostate cancer.
Current problems in surgery 2002;39(9):833-957.
-
2002: Coakley Fergus V; Eberhardt Steven; Kattan Michael W; Wei David C; Scardino Peter T; Hricak Hedvig
Urinary continence after radical retropubic prostatectomy: relationship with membranous urethral length on preoperative endorectal magnetic resonance imaging.
The Journal of urology 2002;168(3):1032-5.
-
2002: LaTulippe Eva; Satagopan Jaya; Smith Alex; Scher Howard; Scardino Peter; Reuter Victor; Gerald William L
Comprehensive gene expression analysis of prostate cancer reveals distinct transcriptional programs associated with metastatic disease.
Cancer research 2002;62(15):4499-506.
-
2002: Graefen Markus; Karakiewicz Pierre I; Cagiannos Ilias; Quinn David I; Henshall Susan M; Grygiel John J; Sutherland Robert L; Stricker Phillip D; Klein Eric; Kupelian Patrick; Skinner Donald G; Lieskovsky Gary; Bochner Bernard; Huland Hartwig; Hammerer Peter G; Haese Alexander; Erbersdobler Andreas; Eastham James A; de Kernion Jean; Cangiano Thomas; Schröder Fritz H; Wildhagen Mark F; van der Kwast Theo H; Scardino Peter T; Kattan Michael W
International validation of a preoperative nomogram for prostate cancer recurrence after radical prostatectomy.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2002;20(15):3206-12.
-
2002: Graefen Markus; Karakiewicz Pierre I; Cagiannos Ilias; Hammerer Peter G; Haese Alexander; Palisaar Jüri; Fernandez Salvador; Noldus Jochen; Erbersdobler Andreas; Huland Hartwig; Scardino Peter T; Kattan Michael W
A validation of two preoperative nomograms predicting recurrence following radical prostatectomy in a cohort of European men.
Urologic oncology 2002;7(4):141-6.
-
2002: Koh Hideshige; Maru Norio; Muramoto Masatoshi; Wheeler Thomas M; Scardino Peter T; Ohori Makoto
[The 1992 TNM classification of T2 prostate cancer predicts pathologic stage and prognosis better than the revised 1997 classification]
Nippon Hinyokika Gakkai zasshi. The japanese journal of urology 2002;93(5):595-601.
-
2002: Coakley Fergus V; Eberhardt Steven; Wei David C; Wasserman Evan S; Heinze Stefan B J; Scardino Peter T; Hricak Hedvig
Blood loss during radical retropubic prostatectomy: relationship to morphologic features on preoperative endorectal magnetic resonance imaging.
Urology 2002;59(6):884-8.
-
2002: Eastham James A; Kattan Michael W; Scardino Peter T
Nomograms as predictive models.
Seminars in urologic oncology 2002;20(2):108-15.
-
2002: Ross Phillip L; Gerigk Claudia; Gonen Mithat; Yossepowitch Ofer; Cagiannos Ilias; Sogani Pramod C; Scardino Peter T; Kattan Michael W
Comparisons of nomograms and urologists' predictions in prostate cancer.
Seminars in urologic oncology 2002;20(2):82-8.
-
2002: Cagiannos Ilias; Graefen Markus; Karakiewicz Pierre I; Ohori Makato; Eastham James A; Rabbani Farhang; Fair William; Wheeler Thomas M; Hammerer Peter G; Haese Alexander; Erbersdobler Andreas; Huland Hartwig; Scardino Peter T; Kattan Michael W
Analysis of clinical stage T2 prostate cancer: do current subclassifications represent an improvement?
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2002;20(8):2025-30.
-
2002: Begg Colin B; Riedel Elyn R; Bach Peter B; Kattan Michael W; Schrag Deborah; Warren Joan L; Scardino Peter T
Variations in morbidity after radical prostatectomy.
The New England journal of medicine 2002;346(15):1138-44.
-
2002: Graefen Markus; Karakiewicz Pierre I; Cagiannos Ilias; Hammerer Peter G; Haese Alexander; Palisaar Jüri; Huland Edith; Scardino Peter T; Kattan Michael W; Huland Hartwig
Percent free prostate specific antigen is not an independent predictor of organ confinement or prostate specific antigen recurrence in unscreened patients with localized prostate cancer treated with radical prostatectomy.
The Journal of urology 2002;167(3):1306-9.
-
2002: Graefen Markus; Karakiewicz Pierre I; Cagiannos Ilias; Klein Eric; Kupelian Patrick A; Quinn David I; Henshall Susan M; Grygiel John J; Sutherland Robert L; Stricker Phillip D; de Kernion Jean; Cangiano Thomas; Schröder Fritz H; Wildhagen Mark F; Scardino Peter T; Kattan Michael W
Validation study of the accuracy of a postoperative nomogram for recurrence after radical prostatectomy for localized prostate cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2002;20(4):951-6.
-
2002: O'Shaughnessy Joyce A; Kelloff Gary J; Gordon Gary B; Dannenberg Andrew J; Hong Waun Ki; Fabian Carol J; Sigman Caroline C; Bertagnolli Monica M; Stratton Steven P; Lam Stephen; Nelson William G; Meyskens Frank L; Alberts David S; Follen Michele; Rustgi Anil K; Papadimitrakopoulou Vali; Scardino Peter T; Gazdar Adi F; Wattenberg Lee W; Sporn Michael B; Sakr Wael A; Lippman Scott M; Von Hoff Daniel D
Treatment and prevention of intraepithelial neoplasia: an important target for accelerated new agent development.
Clinical cancer research : an official journal of the American Association for Cancer Research 2002;8(2):314-46.
-
2002: Scherr Douglas S; Eastham James; Ohori Makoto; Scardino Peter T
Prostate biopsy techniques and indications: when, where, and how?
Seminars in urologic oncology 2002;20(1):18-31.
-
2002: Hull Gerald W; Rabbani Farhang; Abbas Farhat; Wheeler Thomas M; Kattan Michael W; Scardino Peter T
Cancer control with radical prostatectomy alone in 1,000 consecutive patients.
The Journal of urology 2002;167(2 Pt 1):528-34.
-
2001: Kim E D; Nath R; Slawin K M; Kadmon D; Miles B J; Scardino P T
Bilateral nerve grafting during radical retropubic prostatectomy: extended follow-up.
Urology 2001;58(6):983-7.
-
2001: Kothari P S; Scardino P T; Ohori M; Kattan M W; Wheeler T M
Incidence, location, and significance of periprostatic and periseminal vesicle lymph nodes in prostate cancer.
The American journal of surgical pathology 2001;25(11):1429-32.
-
2001: Turlakow A; Larson S M; Coakley F; Akhurst T; Gonen M; Macapinlac H A; Kelly W; Leibel S; Humm J; Scardino P; Scher H; Hricak H
Local detection of prostate cancer by positron emission tomography with 2-fluorodeoxyglucose: comparison of filtered back projection and iterative reconstruction with segmented attenuation correction.
The quarterly journal of nuclear medicine : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR) 2001;45(3):235-44.
-
2001: Eastham J A; Scardino P T
Early diagnosis and treatment of prostate cancer.
Disease-a-month : DM 2001;47(9):421-59.
-
2001: Kattan M W; Potters L; Blasko J C; Beyer D C; Fearn P; Cavanagh W; Leibel S; Scardino P T
Pretreatment nomogram for predicting freedom from recurrence after permanent prostate brachytherapy in prostate cancer.
Urology 2001;58(3):393-9.
-
2001: Maru N; Ohori M; Kattan M W; Scardino P T; Wheeler T M
Prognostic significance of the diameter of perineural invasion in radical prostatectomy specimens.
Human pathology 2001;32(8):828-33.
-
2001: Strom S S; Spitz M R; Yamamura Y; Babaian R J; Scardino P T; Wei Q
Reduced expression of hMSH2 and hMLH1 and risk of prostate cancer: a case-control study.
The Prostate 2001;47(4):269-75.
-
2001: Scardino P T; Kim E D
Rationale for and results of nerve grafting during radical prostatectomy.
Urology 2001;57(6):1016-9.
-
2001: Kim E D; Nath R; Kadmon D; Lipshultz L I; Miles B J; Slawin K M; Tang H Y; Wheeler T; Scardino P T
Bilateral nerve graft during radical retropubic prostatectomy: 1-year followup.
The Journal of urology 2001;165(6 Pt 1):1950-6.
-
2001: Cozzi P J; Malhotra S; McAuliffe P; Kooby D A; Federoff H J; Huryk B; Johnson P; Scardino P T; Heston W D; Fong Y
Intravesical oncolytic viral therapy using attenuated, replication-competent herpes simplex viruses G207 and Nv1020 is effective in the treatment of bladder cancer in an orthotopic syngeneic model.
The FASEB journal : official publication of the Federation of American Societies for Experimental Biology 2001;15(7):1306-8.
-
2001: Ross P L; Scardino P T; Kattan M W
A catalog of prostate cancer nomograms.
The Journal of urology 2001;165(5):1562-8.
-
2001: Herman C M; Kattan M W; Ohori M; Scardino P T; Wheeler T M
Primary Gleason pattern as a predictor of disease progression in gleason score 7 prostate cancer: a multivariate analysis of 823 men treated with radical prostatectomy.
The American journal of surgical pathology 2001;25(5):657-60.
-
2001: Lee C T; Scardino P T
Percent free prostate-specific antigen for first-time prostate biopsy.
Urology 2001;57(4):594-8.
-
2001: Kim E D; Scardino P T; Kadmon D; Slawin K; Nath R K
Interposition sural nerve grafting during radical retropubic prostatectomy.
Urology 2001;57(2):211-6.
-
2001: Chang S; Hursting S D; Contois J H; Strom S S; Yamamura Y; Babaian R J; Troncoso P; Scardino P S; Wheeler T M; Amos C I; Spitz M R
Leptin and prostate cancer.
The Prostate 2001;46(1):62-7.
-
2000: Rabbani F; Stapleton A M; Kattan M W; Wheeler T M; Scardino P T
Factors predicting recovery of erections after radical prostatectomy.
The Journal of urology 2000;164(6):1929-34.
-
2000: Bahnson R R; Hanks G E; Huben R P; Kantoff P; Kozlowski J M; Kuettel M; Lange P H; Logothetis C; Pow-Sang J M; Roach M; Sandler H; Scardino P T; Taylor R J; Urban D A; Walsh P C; Wilson T G;
NCCN Practice Guidelines for Prostate Cancer.
Oncology (Williston Park, N.Y.) 2000;14(11A):111-9.
-
2000: Blute M L; Bergstralh E J; Partin A W; Walsh P C; Kattan M W; Scardino P T; Montie J E; Pearson J D; Slezak J M; Zincke H
Validation of Partin tables for predicting pathological stage of clinically localized prostate cancer.
The Journal of urology 2000;164(5):1591-5.
-
2000: Kattan M W; Zelefsky M J; Kupelian P A; Scardino P T; Fuks Z; Leibel S A
Pretreatment nomogram for predicting the outcome of three-dimensional conformal radiotherapy in prostate cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2000;18(19):3352-9.
-
2000: Catalona W J; Southwick P C; Slawin K M; Partin A W; Brawer M K; Flanigan R C; Patel A; Richie J P; Walsh P C; Scardino P T; Lange P H; Gasior G H; Loveland K G; Bray K R
Comparison of percent free PSA, PSA density, and age-specific PSA cutoffs for prostate cancer detection and staging.
Urology 2000;56(2):255-60.
-
2000: Perez C A; Beyer D C; Blasko J C; Forman J D; Hussey D H; Lee W R; Paryani S B; Pollack A; Potters L; Roach M; Scardino P; Schellhammer P; Leibel S
Definitive external beam irradiation in stage T1 and T2 carcinoma of the prostate. American College of Radiology. ACR Appropriateness Criteria.
Radiology 2000;215 Suppl():1449-72.
-
2000: Roach M; Blasko J C; Perez C A; Beyer D C; Forman J D; Hussey D H; Lee W R; Paryani S B; Pollack A; Potters L; Scardino P; Schellhammer P; Leibel S
Treatment planning for clinically localized prostate cancer. American College of Radiology. ACR Appropriateness Criteria.
Radiology 2000;215 Suppl():1441-8.
-
2000: Perez C A; Beyer D C; Blasko J C; Forman J D; Hussey D H; Lee W R; Paryani S B; Pollack A; Potters L; Roach M; Scardino P; Schellhammer P; Leibel S
Postradical prostatectomy irradiation in carcinoma of the prostate. American College of Radiology. ACR Appropriateness Criteria.
Radiology 2000;215 Suppl():1419-39.
-
2000: Lee W R; Pollack A; Perez C A; Beyer D C; Blasko J C; Forman J D; Hussey D H; Paryani S B; Potters L; Roach M; Scardino P; Schellhammer P; Leibel S
Node-positive prostate cancer. American College of Radiology. ACR Appropriateness Criteria.
Radiology 2000;215 Suppl():1413-8.
-
2000: Pollack A; Paryani S B; Hussey D; Perez C A; Beyer D C; Blasko J C; Forman J D; Lee W R; Potters L; Roach M; Scardino P; Schellhammer P; Leibel S
Locally advanced (high-risk) prostate cancer. American College of Radiology. ACR Appropriateness Criteria.
Radiology 2000;215 Suppl():1401-12.
-
2000: Potters L; Perez C A; Beyer D C; Blasko J C; Forman J D; Hussey D H; Lee W R; Paryani S B; Pollack A; Roach M; Scardino P; Schellhammer P; Leibel S
Permanent source brachytherapy for prostate cancer. American College of Radiology. ACR Appropriateness Criteria.
Radiology 2000;215 Suppl():1383-400.
-
2000: Forman J D; Lee W R; Roach M; Perez C A; Beyer D C; Blasko J C; Hussey D H; Paryani S B; Pollack A; Potters L; Scardino P; Schellhammer P; Leibel S
Staging evaluation for patients with adenocarcinoma of the prostate. American College of Radiology. ACR Appropriateness Criteria.
Radiology 2000;215 Suppl():1373-82.
-
2000: Herman C M; Wilcox G E; Kattan M W; Scardino P T; Wheeler T M
Lymphovascular invasion as a predictor of disease progression in prostate cancer.
The American journal of surgical pathology 2000;24(6):859-63.
-
2000: Shalev M; Kadmon D; Teh B S; Butler E B; Aguilar-Cordova E; Thompson T C; Herman J R; Adler H L; Scardino P T; Miles B J
Suicide gene therapy toxicity after multiple and repeat injections in patients with localized prostate cancer.
The Journal of urology 2000;163(6):1747-50.
-
2000: Spitz M R; Strom S S; Yamamura Y; Troncoso P; Babaian R J; Scardino P T; Wheeler T; Amos C I; von Eschenbach A; Kagan J
Epidemiologic determinants of clinically relevant prostate cancer.
International journal of cancer. Journal international du cancer 2000;89(3):259-64.
-
2000: Catalona W J; Partin A W; Slawin K M; Naughton C K; Brawer M K; Flanigan R C; Richie J P; Patel A; Walsh P C; Scardino P T; Lange P H; deKernion J B; Southwick P C; Loveland K G; Parson R E; Gasior G H
Percentage of free PSA in black versus white men for detection and staging of prostate cancer: a prospective multicenter clinical trial.
Urology 2000;55(3):372-6.
-
2000: Scardino P T
The Gordon Wilson Lecture. Natural history and treatment of early stage prostate cancer.
Transactions of the American Clinical and Climatological Association 2000;111():201-41.
-
1999: Darouiche R O; Smith J A; Hanna H; Dhabuwala C B; Steiner M S; Babaian R J; Boone T B; Scardino P T; Thornby J I; Raad I I
Efficacy of antimicrobial-impregnated bladder catheters in reducing catheter-associated bacteriuria: a prospective, randomized, multicenter clinical trial.
Urology 1999;54(6):976-81.
-
1999: Lowentritt B H; Scardino P T; Miles B J; Orejuela F J; Schatte E C; Slawin K M; Elliott S P; Kim E D
Sildenafil citrate after radical retropubic prostatectomy.
The Journal of urology 1999;162(5):1614-7.
-
1999: Williams G C; Lee A G; Adler H L; Coburn A; Rosas A L; Tang R A; Scardino P T
Bilateral anterior ischemic optic neuropathy and branch retinal artery occlusion after radical prostatectomy.
The Journal of urology 1999;162(4):1384-5.
-
1999: Southwick P C; Catalona W J; Partin A W; Slawin K M; Brawer M K; Flanigan R C; Patel A; Richie J P; Walsh P C; Scardino P T; Lange P H; Gasior G H; Parson R E; Loveland K G
Prediction of post-radical prostatectomy pathological outcome for stage T1c prostate cancer with percent free prostate specific antigen: a prospective multicenter clinical trial.
The Journal of urology 1999;162(4):1346-51.
-
1999: Mootha R K; Butler R; Laucirica R; Scardino P T; Lerner S P
Renal cell carcinoma with an infrarenal vena caval tumor thrombus.
Urology 1999;54(3):561.
-
1999: Hegarty N J; Fitzpatrick J M; Richie J P; Scardino P T; deVere White R W; Schröder F H; Coffey D S
Future prospects in prostate cancer.
The Prostate 1999;40(4):261-8.
-
1999: Herman J R; Adler H L; Aguilar-Cordova E; Rojas-Martinez A; Woo S; Timme T L; Wheeler T M; Thompson T C; Scardino P T
In situ gene therapy for adenocarcinoma of the prostate: a phase I clinical trial.
Human gene therapy 1999;10(7):1239-49.
-
1999: Kattan M W; Wheeler T M; Scardino P T
Postoperative nomogram for disease recurrence after radical prostatectomy for prostate cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1999;17(5):1499-507.
-
1999: Tindall D J; Scardino P T
Defeating prostate cancer: crucial directions for research--excerpt from the report of the Prostate Cancer Progress Review Group.
The Prostate 1999;38(2):166-71.
-
1999: Ohori M; Abbas F; Wheeler T M; Kattan M W; Scardino P T; Lerner S P
Pathological features and prognostic significance of prostate cancer in the apical section determined by whole mount histology.
The Journal of urology 1999;161(2):500-4.
-
1999: Kim E D; Scardino P T; Hampel O; Mills N L; Wheeler T M; Nath R K
Interposition of sural nerve restores function of cavernous nerves resected during radical prostatectomy.
The Journal of urology 1999;161(1):188-92.
-
1999: Adler H L; McCurdy M A; Kattan M W; Timme T L; Scardino P T; Thompson T C
Elevated levels of circulating interleukin-6 and transforming growth factor-beta1 in patients with metastatic prostatic carcinoma.
The Journal of urology 1999;161(1):182-7.
-
1998: Hu J C; Palapattu G S; Kattan M W; Scardino P T; Wheeler T M
The association of selected pathological features with prostate cancer in a single-needle biopsy accession.
Human pathology 1998;29(12):1536-8.
-
1998: Wilcox G; Soh S; Chakraborty S; Scardino P T; Wheeler T M
Patterns of high-grade prostatic intraepithelial neoplasia associated with clinically aggressive prostate cancer.
Human pathology 1998;29(10):1119-23.
-
1998: Yang G; Truong L D; Timme T L; Ren C; Wheeler T M; Park S H; Nasu Y; Bangma C H; Kattan M W; Scardino P T; Thompson T C
Elevated expression of caveolin is associated with prostate and breast cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 1998;4(8):1873-80.
-
1998: Wheeler T M; Dillioglugil O; Kattan M W; Arakawa A; Soh S; Suyama K; Ohori M; Scardino P T
Clinical and pathological significance of the level and extent of capsular invasion in clinical stage T1-2 prostate cancer.
Human pathology 1998;29(8):856-62.
-
1998: Goto Y; Ohori M; Scardino P T
Use of systematic biopsy results to predict pathologic stage in patients with clinically localized prostate cancer: a preliminary report.
International journal of urology : official journal of the Japanese Urological Association 1998;5(4):337-42.
-
1998: Leibman B D; Dillioglugil O; Abbas F; Tanli S; Kattan M W; Scardino P T
Impact of a clinical pathway for radical retropubic prostatectomy.
Urology 1998;52(1):94-9.
-
1998: Leibman B D; Dillioglugil O; Scardino P T; Abbas F; Rogers E; Wolfinger R D; Kattan M W
Prostate-specific antigen doubling times are similar in patients with recurrence after radical prostatectomy or radiotherapy: a novel analysis.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1998;16(6):2267-71.
-
1998: Catalona W J; Partin A W; Slawin K M; Brawer M K; Flanigan R C; Patel A; Richie J P; deKernion J B; Walsh P C; Scardino P T; Lange P H; Subong E N; Parson R E; Gasior G H; Loveland K G; Southwick P C
Use of the percentage of free prostate-specific antigen to enhance differentiation of prostate cancer from benign prostatic disease: a prospective multicenter clinical trial.
JAMA : the journal of the American Medical Association 1998;279(19):1542-7.
-
1998: Kattan M W; Eastham J A; Stapleton A M; Wheeler T M; Scardino P T
A preoperative nomogram for disease recurrence following radical prostatectomy for prostate cancer.
Journal of the National Cancer Institute 1998;90(10):766-71.
-
1998: Stapleton A M; Zbell P; Kattan M W; Yang G; Wheeler T M; Scardino P T; Thompson T C
Assessment of the biologic markers p53, Ki-67, and apoptotic index as predictive indicators of prostate carcinoma recurrence after surgery.
Cancer 1998;82(1):168-75.
-
1997: Butler E B; Scardino P T; Teh B S; Uhl B M; Guerriero W G; Carlton C E; Berner B M; Dennis W S; Carpenter L S; Lu H H; Chiu J K; Kent T S; Woo S Y
The Baylor College of Medicine experience with gold seed implantation.
Seminars in surgical oncology 1997;13(6):406-18.
-
1997: Eastham J A; Kattan M W; Groshen S; Scardino P T; Rogers E; Carlton C E; Lerner S P
Fifteen-year survival and recurrence rates after radiotherapy for localized prostate cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1997;15(10):3214-22.
-
1997: Abbas F; Scardino P T
The natural history of clinical prostate carcinoma.
Cancer 1997;80(5):827-33.
-
1997: Resnick M I; Smith J A; Scardino P T; Egger M J; Hernandez A; Rose S C
Transrectal prostate ultrasonography: variability of interpretation.
The Journal of urology 1997;158(3 Pt 1):856-60.
-
1997: Stapleton A M; Timme T L; Gousse A E; Li Q F; Tobon A A; Kattan M W; Slawin K M; Wheeler T M; Scardino P T; Thompson T C
Primary human prostate cancer cells harboring p53 mutations are clonally expanded in metastases.
Clinical cancer research : an official journal of the American Association for Cancer Research 1997;3(8):1389-97.
-
1997: Dillioglugil O; Leibman B D; Kattan M W; Seale-Hawkins C; Wheeler T M; Scardino P T
Hazard rates for progression after radical prostatectomy for clinically localized prostate cancer.
Urology 1997;50(1):93-9.
-
1997: Soh S; Kattan M W; Berkman S; Wheeler T M; Scardino P T
Has there been a recent shift in the pathological features and prognosis of patients treated with radical prostatectomy?
The Journal of urology 1997;157(6):2212-8.
-
1997: Partin A W; Kattan M W; Subong E N; Walsh P C; Wojno K J; Oesterling J E; Scardino P T; Pearson J D
Combination of prostate-specific antigen, clinical stage, and Gleason score to predict pathological stage of localized prostate cancer. A multi-institutional update.
JAMA : the journal of the American Medical Association 1997;277(18):1445-51.
-
1997: Dillioglugil O; Leibman B D; Leibman N S; Kattan M W; Rosas A L; Scardino P T
Risk factors for complications and morbidity after radical retropubic prostatectomy.
The Journal of urology 1997;157(5):1760-7.
-
1997: Schellhammer P; Cockett A; Boccon-Gibod L; Gospodarowicz M; Krongrad A; Thompson I M; Scardino P; Soloway M; Adolfsson J
Assessment of endpoints for clinical trials for localized prostate cancer.
Urology 1997;49(4A Suppl):27-38.
-
1997: Scardino P T; Hanks G E
A comparison of prostate cancer treatments: are therapeutic implications justified?
The cancer journal from Scientific American 1997;3(2):70-2.
-
1997: Smith J A; Scardino P T; Resnick M I; Hernandez A D; Rose S C; Egger M J
Transrectal ultrasound versus digital rectal examination for the staging of carcinoma of the prostate: results of a prospective, multi-institutional trial.
The Journal of urology 1997;157(3):902-6.
-
1997: Kattan M W; Stapleton A M; Wheeler T M; Scardino P T
Evaluation of a nomogram used to predict the pathologic stage of clinically localized prostate carcinoma.
Cancer 1997;79(3):528-37.
-
1997: Gerber G S; Thisted R A; Chodak G W; Schroder F H; Frohmuller H G; Scardino P T; Paulson D F; Middleton A W; Rukstalis D B; Smith J A; Ohori M; Theiss M; Schellhammer P F
Results of radical prostatectomy in men with locally advanced prostate cancer: multi-institutional pooled analysis.
European urology 1997;32(4):385-90.
-
1996: Abbas F; Scardino P T
Why neoadjuvant androgen deprivation prior to radical prostatectomy is unnecessary.
The Urologic clinics of North America 1996;23(4):587-604.
-
1996: Eastham J A; Kattan M W; Rogers E; Goad J R; Ohori M; Boone T B; Scardino P T
Risk factors for urinary incontinence after radical prostatectomy.
The Journal of urology 1996;156(5):1707-13.
-
1996: Rogers E; Gürpinar T; Dillioglugil O; Kattan M W; Goad J R; Scardino P T; Griffith D P
The role of digital rectal examination, biopsy Gleason sum and prostate-specific antigen in selecting patients who require pelvic lymph node dissections for prostate cancer.
British journal of urology 1996;78(3):419-25.
-
1996: Yang G; Wheeler T M; Kattan M W; Scardino P T; Thompson T C
Perineural invasion of prostate carcinoma cells is associated with reduced apoptotic index.
Cancer 1996;78(6):1267-71.
-
1996: Goto Y; Ohori M; Arakawa A; Kattan M W; Wheeler T M; Scardino P T
Distinguishing clinically important from unimportant prostate cancers before treatment: value of systematic biopsies.
The Journal of urology 1996;156(3):1059-63.
-
1996: Hanks G E; Scardino P T
Does screening for prostate cancer make sense?
Scientific American 1996;275(3):114-5.
-
1996: Gerber G S; Thisted R A; Scardino P T; Frohmuller H G; Schroeder F H; Paulson D F; Middleton A W; Rukstalis D B; Smith J A; Schellhammer P F; Ohori M; Chodak G W
Results of radical prostatectomy in men with clinically localized prostate cancer.
JAMA : the journal of the American Medical Association 1996;276(8):615-9.
-
1996: Bostwick D G; Wheeler T M; Blute M; Barrett D M; MacLennan G T; Sebo T J; Scardino P T; Humphrey P A; Hudson M A; Fradet Y; Miller G J; Crawford E D; Blumenstein B A; Mahran H E; Miles B J
Optimized microvessel density analysis improves prediction of cancer stage from prostate needle biopsies.
Urology 1996;48(1):47-57.
-
1996: Williams R H; Stapleton A M; Yang G; Truong L D; Rogers E; Timme T L; Wheeler T M; Scardino P T; Thompson T C
Reduced levels of transforming growth factor beta receptor type II in human prostate cancer: an immunohistochemical study.
Clinical cancer research : an official journal of the American Association for Cancer Research 1996;2(4):635-40.
-
1996: Rogers E; Eastham J A; Ohori M; Sariyuce O; Aihara M; Wheeler T M; Scardino P T
Impalpable prostate cancer: clinicopathological features.
British journal of urology 1996;77(3):429-32.
-
1996: Yang G; Stapleton A M; Wheeler T M; Truong L D; Timme T L; Scardino P T; Thompson T C
Clustered p53 immunostaining: a novel pattern associated with prostate cancer progression.
Clinical cancer research : an official journal of the American Association for Cancer Research 1996;2(2):399-401.
-
1995: Leibman B D; Dillioglugil O; Wheeler T M; Scardino P T
Distant metastasis after radical prostatectomy in patients without an elevated serum prostate specific antigen level.
Cancer 1995;76(12):2530-4.
-
1995: Goad J R; Eastham J A; Fitzgerald K B; Kattan M W; Collini M P; Yawn D H; Scardino P T
Radical retropubic prostatectomy: limited benefit of autologous blood donation.
The Journal of urology 1995;154(6):2103-9.
-
1995: Ohori M; Wheeler T M; Kattan M W; Goto Y; Scardino P T
Prognostic significance of positive surgical margins in radical prostatectomy specimens.
The Journal of urology 1995;154(5):1818-24.
-
1995: Ohori M; Dunn J K; Scardino P T
Is prostate-specific antigen density more useful than prostate-specific antigen levels in the diagnosis of prostate cancer?
Urology 1995;46(5):666-71.
-
1995: Eastham J A; Truong L D; Rogers E; Kattan M; Flanders K C; Scardino P T; Thompson T C
Transforming growth factor-beta 1: comparative immunohistochemical localization in human primary and metastatic prostate cancer.
Laboratory investigation; a journal of technical methods and pathology 1995;73(5):628-35.
-
1995: Miles B J; Scardino P T; Cowen M; McAuley C
A 72-year-old man with localized prostate cancer.
JAMA : the journal of the American Medical Association 1995;274(18):1426-7.
-
1995: Eastham J A; Stapleton A M; Gousse A E; Timme T L; Yang G; Slawin K M; Wheeler T M; Scardino P T; Thompson T C
Association of p53 mutations with metastatic prostate cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 1995;1(10):1111-8.
-
1995: Arakawa A; Song S; Scardino P T; Wheeler T M
High grade prostatic intraepithelial neoplasia in prostates removed following irradiation failure in the treatment of prostatic adenocarcinoma.
Pathology, research and practice 1995;191(9):868-72.
-
1995: Bochner B H; Lerner S P; Kawachi M; Williams R D; Scardino P T; Skinner D G
Postradical orchiectomy hemorrhage: should an alteration in staging strategy for testicular cancer be considered?
Urology 1995;46(3):408-11.
-
1995: Dalkin B L; Ahmann F R; Kopp J B; Catalona W J; Ratliff T L; Hudson M A; Richie J P; Scardino P T; Flanigan R C; Dekernion J B
Derivation and application of upper limits for prostate specific antigen in men aged 50-74 years with no clinical evidence of prostatic carcinoma.
British journal of urology 1995;76(3):346-50.
-
1995: Miles B J; Scardino P T
Physicians, health care costs, and total quality management.
Journal of the American College of Surgeons 1995;180(5):604-6.
-
1995: Rogers E; Scardino P T
A simple ileal substitute bladder after radical cystectomy: experience with a modification of the Studer pouch.
The Journal of urology 1995;153(5):1432-8.
-
1995: Slawin K M; Ohori M; Dillioglugil O; Scardino P T
Screening for prostate cancer: an analysis of the early experience.
CA: a cancer journal for clinicians 1995;45(3):134-47.
-
1995: Greene D R; Taylor S R; Aihara M; Yoshida K; Egawa S; Park S H; Timme T L; Yang G; Scardino P T; Thompson T C
DNA ploidy and clonal selection in ras + myc-induced mouse prostate cancer.
International journal of cancer. Journal international du cancer 1995;60(3):395-9.
-
1995: Greene D R; Fitzpatrick J M; Scardino P T
Anatomy of the prostate and distribution of early prostate cancer.
Seminars in surgical oncology 1995;11(1):9-22.
-
1995: Aihara M; Scardino P T; Truong L D; Wheeler T M; Goad J R; Yang G; Thompson T C
The frequency of apoptosis correlates with the prognosis of Gleason Grade 3 adenocarcinoma of the prostate.
Cancer 1995;75(2):522-9.
-
1995: Rogers E; Ohori M; Kassabian V S; Wheeler T M; Scardino P T
Salvage radical prostatectomy: outcome measured by serum prostate specific antigen levels.
The Journal of urology 1995;153(1):104-10.
-
1995: Dillioglugil O; Miles B J; Scardino P T
Current controversies in the management of localized prostate cancer.
European urology 1995;28(2):85-101.
-
1994: Catalona W J; Hudson M A; Scardino P T; Richie J P; Ahmann F R; Flanigan R C; deKernion J B; Ratliff T L; Kavoussi L R; Dalkin B L
Selection of optimal prostate specific antigen cutoffs for early detection of prostate cancer: receiver operating characteristic curves.
The Journal of urology 1994;152(6 Pt 1):2037-42.
-
1994: Scardino P T
Problem of prostate cancer.
The Journal of urology 1994;152(5 Pt 2):1677-8.
-
1994: Ohori M; Goad J R; Wheeler T M; Eastham J A; Thompson T C; Scardino P T
Can radical prostatectomy alter the progression of poorly differentiated prostate cancer?
The Journal of urology 1994;152(5 Pt 2):1843-9.
-
1994: Ohori M; Wheeler T M; Dunn J K; Stamey T A; Scardino P T
The pathological features and prognosis of prostate cancer detectable with current diagnostic tests.
The Journal of urology 1994;152(5 Pt 2):1714-20.
-
1994: Flanigan R C; Catalona W J; Richie J P; Ahmann F R; Hudson M A; Scardino P T; deKernion J B; Ratliff T L; Kavoussi L R; Dalkin B L
Accuracy of digital rectal examination and transrectal ultrasonography in localizing prostate cancer.
The Journal of urology 1994;152(5 Pt 1):1506-9.
-
1994: Ohori M; Scardino P T
Early detection of prostate cancer: the nature of cancers detected with current diagnostic tests.
Seminars in oncology 1994;21(5):522-6.
-
1994: Norberg M; Busch C; Stavinoha J; Scardino P T; Magnusson A
Transrectal ultrasound-guided core biopsies of the prostate. A comparison between the standard 1.2-mm needle and three thinner needles.
Acta radiologica (Stockholm, Sweden : 1987) 1994;35(5):463-7.
-
1994: Scardino P T; Carlton C E
Re: Impact of transurethral resection on the long-term outcome of patients with prostatic carcinoma.
The Journal of urology 1994;152(3):970.
-
1994: Aihara M; Truong L D; Dunn J K; Wheeler T M; Scardino P T; Thompson T C
Frequency of apoptotic bodies positively correlates with Gleason grade in prostate cancer.
Human pathology 1994;25(8):797-801.
-
1994: Ohori M; Egawa S; Shinohara K; Wheeler T M; Scardino P T
Detection of microscopic extracapsular extension prior to radical prostatectomy for clinically localized prostate cancer.
British journal of urology 1994;74(1):72-9.
-
1994: Ohori M; Wheeler T M; Scardino P T
The New American Joint Committee on Cancer and International Union Against Cancer TNM classification of prostate cancer. Clinicopathologic correlations.
Cancer 1994;74(1):104-14.
-
1994: Scardino P T; Beck J R; Miles B J
Conservative management of prostate cancer.
The New England journal of medicine 1994;330(25):1831; author reply 1831-2.
-
1994: Aihara M; Lebovitz R M; Wheeler T M; Kinner B M; Ohori M; Scardino P T
Prostate specific antigen and gleason grade: an immunohistochemical study of prostate cancer.
The Journal of urology 1994;151(6):1558-64.
-
1994: Greene D R; Rogers E; Wessels E C; Wheeler T M; Taylor S R; Santucci R A; Thompson T C; Scardino P T
Some small prostate cancers are nondiploid by nuclear image analysis: correlation of deoxyribonucleic acid ploidy status and pathological features.
The Journal of urology 1994;151(5):1301-7.
-
1994: Catalona W J; Richie J P; Ahmann F R; Hudson M A; Scardino P T; Flanigan R C; deKernion J B; Ratliff T L; Kavoussi L R; Dalkin B L
Comparison of digital rectal examination and serum prostate specific antigen in the early detection of prostate cancer: results of a multicenter clinical trial of 6,630 men.
The Journal of urology 1994;151(5):1283-90.
-
1994: Aihara M; Wheeler T M; Ohori M; Scardino P T
Heterogeneity of prostate cancer in radical prostatectomy specimens.
Urology 1994;43(1):60-6; discussion 66-7.
-
1994: Beck J R; Scardino P T
How useful are models of natural history in clinical decision making and clinical research?
Journal of clinical epidemiology 1994;47(1):1-2.
-
1994: Wheeler T M; Rogers E; Aihara M; Scardino P T; Thompson T C
Apoptotic index as a biomarker in prostatic intraepithelial neoplasia (PIN) and prostate cancer.
Journal of cellular biochemistry. Supplement 1994;19():202-7.
-
1993: Ohori M; Scardino P T; Lapin S L; Seale-Hawkins C; Link J; Wheeler T M
The mechanisms and prognostic significance of seminal vesicle involvement by prostate cancer.
The American journal of surgical pathology 1993;17(12):1252-61.
-
1993: Ohori M; Shinohara K; Wheeler T M; Aihara M; Wessels E C; Carter S S; Scardino P T
Ultrasonic detection of non-palpable seminal vesicle invasion: a clinicopathological study.
British journal of urology 1993;72(5 Pt 2):799-808.
-
1993: Goad J R; Chang S J; Ohori M; Scardino P T
PSA after definitive radiotherapy for clinically localized prostate cancer.
The Urologic clinics of North America 1993;20(4):727-36.
-
1993: Slawin K; Kadmon D; Park S H; Scardino P T; Anzano M; Sporn M B; Thompson T C
Dietary fenretinide, a synthetic retinoid, decreases the tumor incidence and the tumor mass of ras+myc-induced carcinomas in the mouse prostate reconstitution model system.
Cancer research 1993;53(19):4461-5.
-
1993: Kassabian V S; Bottles K; Weaver R; Williams R D; Paulson D F; Scardino P T
Possible mechanism for seeding of tumor during radical prostatectomy.
The Journal of urology 1993;150(4):1169-71.
-
1993: Richie J P; Catalona W J; Ahmann F R; Hudson M A; Scardino P T; Flanigan R C; deKernion J B; Ratliff T L; Kavoussi L R; Dalkin B L
Effect of patient age on early detection of prostate cancer with serum prostate-specific antigen and digital rectal examination.
Urology 1993;42(4):365-74.
-
1993: Thompson T C; Truong L D; Timme T L; Kadmon D; McCune B K; Flanders K C; Scardino P T; Park S H
Transgenic models for the study of prostate cancer.
Cancer 1993;71(3 Suppl):1165-71.
-
1993: Truong L D; Kadmon D; McCune B K; Flanders K C; Scardino P T; Thompson T C
Association of transforming growth factor-beta 1 with prostate cancer: an immunohistochemical study.
Human pathology 1993;24(1):4-9.
-
1993: Ohori M; Wheeler T M; Greene D R; Scardino P T
Comparison of the pathologic features and DNA ploidy value of prostate cancers detectable by sonography and by palpation.
The Prostate 1993;23(4):271-81.
-
1992: Thompson T C; Egawa S; Kadmon D; Miller G J; Timme T L; Scardino P T; Park S H
Androgen sensitivity and gene expression in ras + myc-induced mouse prostate carcinomas.
The Journal of steroid biochemistry and molecular biology 1992;43(1-3):79-85.
-
1992: Egawa S; Carter S S; Wheeler T M; Scardino P T
Sonographic monitoring of prostate cancer after definitive radiotherapy.
Urology 1992;40(3):230-6.
-
1992: Rosen M A; Goldstone L; Lapin S; Wheeler T; Scardino P T
Frequency and location of extracapsular extension and positive surgical margins in radical prostatectomy specimens.
The Journal of urology 1992;148(2 Pt 1):331-7.
-
1992: Bostwick D G; Cooner W H; Denis L; Jones G W; Scardino P T; Murphy G P
The association of benign prostatic hyperplasia and cancer of the prostate.
Cancer 1992;70(1 Suppl):291-301.
-
1992: Egawa S; Wheeler T M; Greene D R; Scardino P T
Detection of residual prostate cancer after radiotherapy by sonographically guided needle biopsy.
Urology 1992;39(4):358-63.
-
1992: Scardino P T; Weaver R; Hudson M A
Early detection of prostate cancer.
Human pathology 1992;23(3):211-22.
-
1992: Harrison S H; Seale-Hawkins C; Schum C W; Dunn J K; Scardino P T
Correlation between side of palpable tumor and side of pelvic lymph node metastasis in clinically localized prostate cancer.
Cancer 1992;69(3):750-4.
-
1992: Egawa S; Wheeler T M; Greene D R; Scardino P T
Unusual hyperechoic appearance of prostate cancer on transrectal ultrasonography.
British journal of urology 1992;69(2):169-74.
-
1992: Egawa S; Kadmon D; Miller G J; Scardino P T; Thompson T C
Alterations in mRNA levels for growth-related genes after transplantation into castrated hosts in oncogene-induced clonal mouse prostate carcinoma.
Molecular carcinogenesis 1992;5(1):52-61.
-
1992: Thompson T C; Truong L D; Timme T L; Kadmon D; McCune B K; Flanders K C; Scardino P T; Park S H
Transforming growth factor beta 1 as a biomarker for prostate cancer.
Journal of cellular biochemistry. Supplement 1992;16H():54-61.
-
1991: Holzman M; Carlton C E; Scardino P T
The frequency and morbidity of local tumor recurrence after definitive radiotherapy for stage C prostate cancer.
The Journal of urology 1991;146(6):1578-82.
-
1991: Greene D R; Wheeler T M; Egawa S; Weaver R P; Scardino P T
Relationship between clinical stage and histological zone of origin in early prostate cancer: morphometric analysis.
British journal of urology 1991;68(5):499-509.
-
1991: Lamm D L; Blumenstein B A; Crawford E D; Montie J E; Scardino P; Grossman H B; Stanisic T H; Smith J A; Sullivan J; Sarosdy M F
A randomized trial of intravesical doxorubicin and immunotherapy with bacille Calmette-Guérin for transitional-cell carcinoma of the bladder.
The New England journal of medicine 1991;325(17):1205-9.
-
1991: Greene D R; Wheeler T M; Egawa S; Dunn J K; Scardino P T
A comparison of the morphological features of cancer arising in the transition zone and in the peripheral zone of the prostate.
The Journal of urology 1991;146(4):1069-76.
-
1991: Lerner S P; Seale-Hawkins C; Carlton C E; Scardino P T
The risk of dying of prostate cancer in patients with clinically localized disease.
The Journal of urology 1991;146(4):1040-5.
-
1991: Egawa S; Wheeler T M; Scardino P T
The sonographic appearance of irradiated prostate cancer.
British journal of urology 1991;68(2):172-7.
-
1991: Egawa S; Greene D R; Flanagan W F; Wheeler T M; Scardino P T
Transrectal ultrasonography in stage A prostate cancer: detection of residual tumor after transurethral resection of prostate.
The Journal of urology 1991;146(2):366-71.
-
1991: Kadmon D; Thompson T C; Lynch G R; Scardino P T
Elevated plasma chromogranin-A concentrations in prostatic carcinoma.
The Journal of urology 1991;146(2):358-61.
-
1991: Greene D R; Taylor S R; Wheeler T M; Scardino P T
DNA ploidy by image analysis of individual foci of prostate cancer: a preliminary report.
Cancer research 1991;51(15):4084-9.
-
1991: Iammarino N K; Scardino P T
Testicular cancer: the role of the primary care physician in prevention and early detection.
Texas medicine 1991;87(5):66-71.
-
1991: Merz V W; Miller G J; Krebs T; Timme T L; Kadmon D; Park S H; Egawa S; Scardino P T; Thompson T C
Elevated transforming growth factor-beta 1 and beta 3 mRNA levels are associated with ras + myc-induced carcinomas in reconstituted mouse prostate: evidence for a paracrine role during progression.
Molecular endocrinology (Baltimore, Md.) 1991;5(4):503-13.
-
1991: Greene D R; Egawa S; Neerhut G; Flanagan W; Wheeler T M; Scardino P T
The distribution of residual cancer in radical prostatectomy specimens in stage A prostate cancer.
The Journal of urology 1991;145(2):324-8; discussion 328-9.
-
1991: Scardino P T
What's new in surgery for 1991? Urology.
Bulletin of the American College of Surgeons 1991;76(1):59-62.
-
1991: Thompson T C; Kadmon D; Timme T L; Merz V W; Egawa S; Krebs T; Scardino P T; Park S H
Experimental oncogene induced prostate cancer.
Cancer surveys 1991;11():55-71.
-
1990: Rawls W H; Lamm D L; Lowe B A; Crawford E D; Sarosdy M F; Montie J E; Grossman H B; Scardino P T
Fatal sepsis following intravesical bacillus Calmette-Guerin administration for bladder cancer.
The Journal of urology 1990;144(6):1328-30.
-
1990: Greene D R; Egawa S; Hellerstein D K; Scardino P T
Sonographic measurements of transition zone of prostate in men with and without benign prostatic hyperplasia.
Urology 1990;36(4):293-9.
-
1989: Egawa S; Carter S S; Wheeler T M; Scardino P T
Ultrasonographic changes in the normal and malignant prostate after definitive radiotherapy.
The Urologic clinics of North America 1989;16(4):741-9.
-
1989: Scardino P T; Shinohara K; Wheeler T M; Carter S S
Staging of prostate cancer. Value of ultrasonography.
The Urologic clinics of North America 1989;16(4):713-34.
-
1989: Shinohara K; Scardino P T; Carter S S; Wheeler T M
Pathologic basis of the sonographic appearance of the normal and malignant prostate.
The Urologic clinics of North America 1989;16(4):675-91.
-
1989: Scardino P T
Early detection of prostate cancer.
The Urologic clinics of North America 1989;16(4):635-55.
-
1989: Gervasi L A; Mata J; Easley J D; Wilbanks J H; Seale-Hawkins C; Carlton C E; Scardino P T
Prognostic significance of lymph nodal metastases in prostate cancer.
The Journal of urology 1989;142(2 Pt 1):332-6.
-
1989: Meacham R B; Scardino P T; Hoffman G S; Easley J D; Wilbanks J H; Carlton C E
The risk of distant metastases after transurethral resection of the prostate versus needle biopsy in patients with localized prostate cancer.
The Journal of urology 1989;142(2 Pt 1):320-5.
-
1989: Shinohara K; Wheeler T M; Scardino P T
The appearance of prostate cancer on transrectal ultrasonography: correlation of imaging and pathological examinations.
The Journal of urology 1989;142(1):76-82.
-
1989: Scardino P T
Transrectal ultrasound in management of prostate cancer.
Urology 1989;33(6 Suppl):27-31.
-
1989: Scardino P T
Is radiotherapy effective for locally advanced (stage C or T3) prostate cancer?
Progress in clinical and biological research 1989;303():223-39.
-
1989: Lamm D L; Crissmann J; Blumenstein B; Crawford E D; Montie J; Scardino P; Grossman H B; Stanisic T; Smith J; Sullivan J
Adriamycin versus BCG in superficial bladder cancer: a Southwest Oncology Group Study.
Progress in clinical and biological research 1989;310():263-70.
-
1988: Meacham R B; Mata J A; Espada R; Wheeler T M; Schum C W; Scardino P T
Testicular metastasis as the first manifestation of colon carcinoma.
The Journal of urology 1988;140(3):621-2.
-
1988: Neerhut G J; Wheeler T; Cantini M; Scardino P T
Salvage radical prostatectomy for radiorecurrent adenocarcinoma of the prostate.
The Journal of urology 1988;140(3):544-9.
-
1988: Murphy G P; Priore R L; Scardino P T
Hormone-refractory metastatic prostatic cancer treated with methotrexate, cyclophosphamide plus adriamycin, cis-platinum plus 5-fluorouracil plus cyclophosphamide. National Prostatic Cancer Project randomized trial.
Urology 1988;32(1):33-40.
-
1988: Young C Y; Murthy L R; Prescott J L; Johnson M P; Rowley D R; Cunningham G R; Killian C S; Scardino P T; VonEschenbach A; Tindall D J
Monoclonal antibodies against the androgen receptor: recognition of human and other mammalian androgen receptors.
Endocrinology 1988;123(1):601-10.
-
1988: Scardino P T; Wheeler T M
Local control of prostate cancer with radiotherapy: frequency and prognostic significance of positive results of postirradiation prostate biopsy.
NCI monographs : a publication of the National Cancer Institute 1988;(7):95-103.
-
1987: Yu D; Pietro T; Jurco S; Scardino P T
Identification of "tumor-associated" nucleolar antigens in human urothelial cancer.
The Journal of urology 1987;138(3):636-9.
-
1987: Carlton C E; Scardino P T
Combined interstitial and external irradiation for prostatic cancer.
Progress in clinical and biological research 1987;243B():141-69.
-
1986: Light J K; Scardino P T
Radical cystectomy with preservation of sexual and urinary function. Use of the ileocolonic pouch ("Le Bag").
The Urologic clinics of North America 1986;13(2):261-9.
-
1986: Scardino P T; Frankel J M; Wheeler T M; Meacham R B; Hoffman G S; Seale C; Wilbanks J H; Easley J; Carlton C E
The prognostic significance of post-irradiation biopsy results in patients with prostatic cancer.
The Journal of urology 1986;135(3):510-6.
-
1986: Fujino A; Scardino P T
Transrectal ultrasonography for prostatic cancer. II. The response of the prostate to definitive radiotherapy.
Cancer 1986;57(5):935-40.
-
1986: Scardino P T
The treatment of localized prostatic cancer.
Scandinavian journal of urology and nephrology 1986;20(1):1-8.
-
1986: Murthy L R; Johnson M P; Rowley D R; Young C Y; Scardino P T; Tindall D J
Characterization of steroid receptors in human prostate using mibolerone.
The Prostate 1986;8(3):241-53.
-
1985: Libby J M; Frankel J M; Scardino P T
Condyloma acuminatum of the bladder and associated urothelial malignancy.
The Journal of urology 1985;134(1):134-6.
-
1985: Fujino A; Scardino P T
Transrectal ultrasonography for prostatic cancer: its value in staging and monitoring the response to radiotherapy and chemotherapy.
The Journal of urology 1985;133(5):806-10.
-
1985: Scardino P T; Wheeler T M
Prostatic biopsy after irradiation therapy for prostatic cancer.
Urology 1985;25(2 Suppl):39-46.
-
1984: Murthy L R; Chang C H; Rowley D R; Scardino P T; Tindall D J
Physicochemical characterization of the androgen receptor from hyperplastic human prostate.
The Prostate 1984;5(6):567-79.
-
1983: Scardino P T
The prognostic significance of biopsies after radiotherapy for prostatic cancer.
Seminars in urology 1983;1(4):243-52.
-
1983: Gibbons R P; Beckley S; Brady M F; Chu T M; Dekernion J B; Dhabuwala C; Gaeta J F; Loening S A; McKiel C F; McLeod D G; Pontes J E; Prout G R; Scardino P T; Schlegel J U; Schmidt J D; Scott W W; Slack N H; Soloway M S; Murphy G P
The addition of chemotherapy to hormonal therapy for treatment of patients with metastatic carcinoma of the prostate.
Journal of surgical oncology 1983;23(2):133-42.
-
1983: Wise P G; Scardino P T
Thoracoabdominal retroperitoneal lymphadenectomy for nonseminomatous testicular cancer.
The Urologic clinics of North America 1983;10(2):371-9.
-
1983: Loening S A; Beckley S; Brady M F; Chu T M; deKernion J B; Dhabuwala C; Gaeta J F; Gibbons R P; McKiel C F; McLeod D G; Pontes J E; Prout G R; Scardino P T; Schlegel J U; Schmidt J D; Scott W W; Slack N H; Soloway M S; Murphy G P
Comparison of estramustine phosphate, methotrexate and cis-platinum in patients with advanced, hormone refractory prostate cancer.
The Journal of urology 1983;129(5):1001-6.
-
1983: Murphy G P; Beckley S; Brady M F; Chu T M; deKernion J B; Dhabuwala C; Gaeta J F; Gibbons R P; Loening S A; McKiel C F; McLeod D G; Pontes J E; Prout G R; Scardino P T; Schlegel J U; Schmidt J D; Scott W W; Slack N H; Soloway M S
Treatment of newly diagnosed metastatic prostate cancer patients with chemotherapy agents in combination with hormones versus hormones alone.
Cancer 1983;51(7):1264-72.
-
1983: Fukutani K; Libby J M; Panko W B; Scardino P T
Human chorionic gonadotropin detected in urinary concentrates from patients with malignant tumors of the testis, prostate, bladder, ureter and kidney.
The Journal of urology 1983;129(1):74-7.
-
1983: Soloway M S; Beckley S; Brady M F; Chu T M; deKernion J B; Dhabuwala C; Gaeta J F; Gibbons R P; Loening S A; McKiel C F; McLeod D G; Pontes J E; Prout G R; Scardino P T; Schlegel J U; Schmidt J D; Scott W W; Slack N H; Murphy G P
A comparison of estramustine phosphate versus cis-platinum alone versus estramustine phosphate plus cis-platinum in patients with advanced hormone refractory prostate cancer who had had extensive irradiation to the pelvis or lumbosacral area.
The Journal of urology 1983;129(1):56-61.
-
1982: Bloom D A; Scardino P T; Ehrlich R M; Waisman J
The significance of lymph nodal involvement in renal angiomyolipoma.
The Journal of urology 1982;128(6):1292-5.
-
1982: Ehrlich R M; Scardino P T
Surgical correction of scrotal transposition and perineal hypospadias.
Journal of pediatric surgery 1982;17(2):175-7.
-
1981: Ehrlich R M; Scardino P T
Simultaneous surgical correction of scrotal transposition and perineal hypospadias.
The Urologic clinics of North America 1981;8(3):531-7.
-
1981: Skinner D G; Scardino P T; Daniels J R
Testicular cancer.
Annual review of medicine 1981;32():543-57.
-
1980: Scardino P T
Adjuvant chemotherapy is of value following retroperitoneal lymph node dissection for nonseminomatous testicular tumors.
The Urologic clinics of North America 1980;7(3):735-45.
-
1980: Lange P H; Nochomovitz L E; Rosai J; Fraley E E; Kennedy B J; Bosl G; Brisbane J; Catalona W J; Cochran J S; Comisarow R H; Cummings K B; deKernion J B; Einhorn L H; Hakala T R; Jewett M; Moore M R; Scardino P T; Streitz J M
Serum alpha-fetoprotein and human chorionic gonadotropin in patients with seminoma.
The Journal of urology 1980;124(4):472-8.
-
1980: Goodwin W E; Scardino P T
Vesicovaginal and ureterovaginal fistulas: a summary of 25 years of experience.
The Journal of urology 1980;123(3):370-4.
-
1980: Skinner D G; Scardino P T
Relevance of biochemical tumor markers and lymphadenectomy in management of non-seminomatous testis tumors: current perspective.
The Journal of urology 1980;123(3):378-82.
-
1979: Kurman R J; Scardino P T; McIntire K R; Waldmann T A; Javadpour N; Norris H J
Malignant germ cell tumors of the ovary and testis. An immunohistologic study of 69 cases.
Annals of clinical and laboratory science 1979;9(6):462-6.
-
1979: Scardino P T; Skinner D G
Germ-cell tumors of the testis: improved results in a prospective study using combined modality therapy and biochemical tumor markers.
Surgery 1979;86(1):86-93.
-
1979: Goodwin W E; Scardino P T
Vesicovaginal and ureterovaginal fistulas: a summary of 25 years of experience.
Transactions of the American Association of Genito-Urinary Surgeons 1979;71():123-9.
-
1979: Skinner D G; Scardino P T
Relevance of biochemical tumor markers and lymphadenectomy in management of non-seminomatous testis tumors: current perspective.
Transactions of the American Association of Genito-Urinary Surgeons 1979;71():31-5.
-
1978: Lieber M M; Kunin M; Scardino P T; Waisman J; Eilber F R; Kaufman J J
Innominate bone and renal masses in a young man.
The Journal of urology 1978;120(5):607-12.
-
1978: Javadpour N; McIntire K R; Waldmann T A; Scardino P T; Bergman S; Anderson T
The role of the radioimmunoassay of serum alpha-fetoprotein and human chorionic gonadotropin in the intensive chemotherapy and surgery of metastatic testicular tumors.
The Journal of urology 1978;119(6):759-62.
-
1977: Scardino P T; Cox H D; Waldmann T A; Mcintire K R; Mittemeyer B; Javadpour N
The value of serum tumor markers in the staging and prognosis of germ cell tumors of the testis.
The Journal of urology 1977;118(6):994-9.
-
1977: Kurman R J; Scardino P T; McIntire K R; Waldmann T A; Javadpour N
Cellular localization of alpha-fetoprotein and human chorionic gonadotropin in germ cell tumors of the testis using and indirect immunoperoxidase technique.
Cancer 1977;40(5):2136-51.
-
1977: Goodwin W E; Scardino P T
Ureterosigmoidostomy.
The Journal of urology 1977;118(1 Pt 2):169-74.
-
1977: Sukov R J; Scardino P T; Sample W F; Winter J; Confer D J
Computed tomography and transabdominal ultrasound in the evaluation of the prostate.
Journal of computer assisted tomography 1977;1(3):281-9.
-
1977: Javadpour N; Scardino P T
Recent advances in immunobiology of genitourinary cancer.
Urology 1977;9(4):377-84.
-
1976: Javadpour N; Doppman J L; Scardino P T; Bartter F C
Segmental renal vein renin assay and segmental nephrectomy for correction of renal hypertension.
The Journal of urology 1976;115(5):580-2.
-
1976: Bernstein A; Scardino P T; Tomaszewki M M; Cohen M H
Carcinoma arising in a branchial cleft cyst.
Cancer 1976;37(5):2417-22.
-
1975: Scardino P T; Bagley D H; Javadpour N; Ketcham A S
Sigmoid conduit urinary diversion.
Urology 1975;6(2):167-71.
-
1974: Javadpour N; Hyatt C; Scardino P T
Fetal antigens' cross-reactivity with transformed prostatic tissue.
Surgical forum 1974;25(0):98-9.
-
1973: Scardino P T; Paulson D F; Glenn J F
Transient significant bacteriuria in women.
The Journal of urology 1973;109(3):464-6.
Sign-in to see more
